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Ethics is a central aspect in scientific 
research and it is more than law. 
The aim of this study was to describe 
the ethical aspects of human tissue 
research and to learn how the stake-
holders in research involving human 
tissues perceive their participation 
and how the protection of their rights 
is guaranteed by current ethical 
practise. Research using human tis-
sue may increase in the future e.g. 
when large biobanks are established. 
Views of different stakeholders in 
research could contribute to research 
ethics by both improving the ethical 
conduct of recruitment and increas-
ing participation.
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ABSTRACT 
 
Ethics is a central aspect in scientific research. Most of the studies on ethics have focused on 
informed consent from the point of view of the participants. There are few studies on the 
views of different stakeholders in research using human tissues. However, this kind of 
data, if available, could contribute to research ethics by both improving the ethical conduct 
of recruitment and may increase participation.   
 
The aim of this study was to describe the ethical aspects of tissue research and to learn how 
the stakeholders in research involving human tissues perceive their participation and how 
the protection of their rights is guaranteed by the ethical framework.  
 
The study consisted of four stages. Studies 1-2 included interviews with mothers (n=25) 
who donated their placenta for placental perfusion studies and with midwives (n=20) who 
were involved in recruiting mothers for the placental perfusion studies. Study 3 
participants were researchers (n=23) who were participated in perfusions studies of human 
placenta, representing nine different nationalities. The data in study 3 were collected from 
the researchers by focus group interviews (n=12) and an open-ended questionnaire (n=19,  
eight also attended a group session). In study 4, the data consisted of scientists’ ethical 
statements (n=56) which were collected from all the applications (n=688) received by the 
official regional ethics committee in the Hospital District of Northern Savo during 2004-
2009. The data were analyzed by using thematic content analysis.  
 
The stakeholders in placental perfusion studies considered the perfusion study as 
important, and in particular the mothers and midwives supported the use of placentas for 
such purposes. This study revealed the challenges encountered in clinical research 
concerning successful recruitment and the informed consent process in order that potential 
participants can give informed consent for research. Societal meaning of tissue research is 
multidimensional and consists of the significance of scientific knowledge, the public image 
of science and aspects of research ethics. Active communication was regarded as crucial 
and should include both the public and the scientific community.  
 
In conclusion, tissue research was seen as important since it benefits society as whole. If 
research projects are be conducted in an ethically acceptable manner, then they must based 
on a functional organizational structure and cooperation with research group. The 
significance of ethical topics in the use of human tissue for research purposes will still 
further increase in the future. Therefore, continuing awareness and education about 
research ethics is essential.  
 
National Library of Medical Classification: W 20.55.E7, W 20.55.F4 
Medical Subject Headings: Ethics, Bioethical Issues, Informed Consent, Fetal Research, Qualitative Research, 
Research Ethics Committee 
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TIIVISTELMÄ 
 
Etiikka on keskeinen osa tieteellistä tutkimusta. Etiikan alalla tutkimukset ovat 
kohdentuneet pääasiassa tietoon perustuvan suostumuksen toteutumiseen tutkittavien 
näkökulmasta. Eri viiteryhmien näkemyksiä tutkimusetiikasta on julkaistu niukasti. Tältä 
alueelta tutkimustiedon tuottaminen voi edistää eettisten näkökohtien huomioon ottamista 
rekrytoinnissa ja siten lisätä osallistumista tutkimukseen. Tämän tutkimuskokonaisuuden 
tarkoituksena on kuvata kudostutkimuksen eettisiä näkökohtia sekä eri viiteryhmien 
osallisuutta ja oikeuksien toteutumista eettisestä näkökulmasta tieteellisessä 
kudostutkimuksessa.  
 
Tutkimuskokonaisuus koostuu neljästä osatutkimuksesta. Näistä kahden ensimmäisen 
empiirisinä aineistoina olivat äitien (n=25) ja kätilöiden (n=20) haastattelut. Äidit 
luovuttivat istukan perfuusiotutkimukseen ja kätilöt osallistuivat äitien rekrytointiin.  
Kolmas osatutkimus kohdentui istukkaperfuusion tutkijoihin, jotka edustivat yhdeksää eri 
kansallisuutta. Aineisto kerättiin ryhmähaastattelun (n=12) ja avoimia kysymyksiä 
sisältäneellä kyselylomakkeella (n=19, näistä kahdeksan tutkijaa osallistui myös 
ryhmähaastatteluun) avulla. Neljäs osatutkimus koostui vastaavien tutkijoiden eettisistä 
lausunnoista (n=56), jotka kerättiin Pohjois-Savon sairaanhoitopiirin tutkimuseettiselle 
toimikunnalle toimitetuista lausuntohakemuksista (n=688) vuosilta 2004–2009. Aineistot 
analysoitiin temaattisen sisällön analyysillä.  
 
Viiteryhmät pitivät istukkaperfuusiotutkimusta tärkeänä. Erityisesti äitien sekä kätilöiden 
mielestä istukan käyttäminen tällaiseen tutkimukseen on merkittävää. Tämä tutkimus 
osoitti rekrytoinnin onnistumisen ja tietoon perustuvan suostumuksen kannalta tärkeitä 
haasteita kliinisessä tutkimuksessa. Suostumuksen hankkimisprosessi on suunniteltava 
huolellisesti, jotta tutkimukseen osallistuva pystyy antamaan tietoon perustuvan 
suostumuksensa. Kudostutkimuksen yhteiskunnallinen merkitys on moniulotteinen. 
Keskeisiä elementtejä siinä ovat tieteellisen tiedon painoarvo (merkittävyys), tieteen profiili 
ja tutkimusetiikka. Aktiivista kommunikaatiota sekä eri viiteryhmien välillä että 
kansalaisten, poliittisten päättäjien ja tieteellisen yhteisön välillä, pidettiin 
välttämättömänä.    
 
Kudostutkimus on tärkeää, eteenkin, jos se hyödyttää koko yhteiskuntaa. Kliinisen 
tutkimuksen onnistuminen eettisesti hyväksyttävällä tavalla edellyttää myös organisaation 
hallinnossa toimijoiden ja tutkimusryhmän välistä yhteistyötä. Eettisten näkökohtien 
merkitys kudostutkimuksessa kasvaa tulevaisuudessa, jonka vuoksi tutkimusetiikan 
koulutus on tarpeen.  
 
 
Yleinen Suomalainen asiasanasto: etiikka, tutkimusetiikka, bioetiikka, istukka, tietoon perustuva suostumus, 
sisällönanalyysi, kvalitatiivinen tutkimus 
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 1 Introduction  
Ethics is a core component of all in scientific research. It is a generic term for various ways 
of understanding and examining moral life (Beauchamp & Childress 2001). The ethics of 
medicine have developed from the time of Hippocrates to the present day (Beauchamp & 
Childress 2001), in fact experiments on human beings may be as old as medicine itself 
(Leder 2009). Socially marginal and physically vulnerable individuals, like slaves and 
prisoners, were often subjects for human experimentation. Experiments performed by Nazi 
doctors are recognized as being the most heinous medical crimes against humanity in the 
twentieth century (Leder 2009). These historical incidents of questionable practices in 
human biomedical research created the need for international regulations e.g. the 
Nuremberg Code in 1947 and later the Declaration of Helsinki (1964-2008), which detail the 
ethical principles for medical research involving human subjects and it is a binding 
declaration for physicians. In the past decades, a number of regulations about medical 
research have been issued both at the international and national levels (WMA, World 
Medical Association, 2011).  The Declaration of Helsinki defines that pre-evaluation of the 
research plan should be performed by an independent research ethics committee 
(Beauchamp & Childress 2001, Halila 2007, WMA 2011). The Declaration of Helsinki had an 
influence on the establishment of ethics committees worldwide and this triggered a shift 
towards focusing on the moral obligation of obtaining the informed consent of research 
subjects (Beauchamp & Childress 2001, Vähäkangas 2004, Halila 2007, Ebbesen 2009, 2011).  
In Finland, according to the current legislation, five health care districts have official 
research ethics committees that evaluate all biomedical studies on humans and human 
tissues from an ethical and legal perspective (Keränen et al. 2011).  
The Declaration of Helsinki has been incorporated into the laws and/or legislations of 
many countries, including Finland, and international conventions such as the convention 
on Biomedicine of the Council of Europe, the CIOMS Guidelines on Biomedical Research 
and the UNESCO Declaration on Biomedicine (Halila 2007). As a consequence of the 
development of medical science and related biomedical ethics, the discipline of bioethics 
was also established. Much of the research conducted within the academic philosophical 
disciplines of bioethics has focussed on theoretical reflections on the adequacy of ethical 
theories and principles (Pellegrino 1999, Ebbesen 2009, 2011). Nevertheless, ethical 
dilemmas resulting from rapid medical progress mean that one must to view bioethics as a 
social movement. Increasingly, bioethics is moving towards multidisciplinary collaboration 
(Pellegrino 1999).  The most commonly used principles are the so- called four principles of 
biomedical ethics: autonomy, justice, beneficence and non-maleficence (Beauchamp & 
Childress 2001). However, alternative principles have been introduced (Rendtorff 2002, 
Ebbesen 2009, Lev 2011, Vähäkangas 2011) and lately there has been a shift towards a more 
global perspective (Ijsselmuiden et al. 2010, Vähäkangas 2011) and solidarity (Lev 2011, 
Vähäkangas 2011).  Two major points have arisen, those also find support in the literature, 
first biomedical principles should be employed to promote discussion (Häyry 2003) and 
secondly they should be used in everyday work in biomedical practice (Ebbesen & 
Pedersen 2007, 2008).  Overall, discussions in research ethics need to continue (Lipworth et 
al. 2008, Vähäkangas 2008, Anderson & Sieber 2009). Incidents of questionable practices in 
human biomedical research have also occurred in recent history (e.g. see White 2005, 
Caplan & Moreno 2011). 
Science is a developing and ongoing process and ethics should be of the forefront of this 
development (Vähäkangas 2004) and there is a need for humanization of medical education 
and practice for healthcare personnel (Pellegrino 1999). In Finland, a government bill called 
the Act of Biobank has been introduced to Parliament in October 2011, and if Parliament 
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agrees, the Act will come into force in 2013. Nevertheless, there has been little discussion 
about tissues used in research in Finland (Tupasela 2004, Vähäkangas & Länsimies 2004) 
although public opinion is considered as being important (Tupasela 2004, Vähäkangas & 
Länsimies 2004, Tupasela et al. 2007).  
There is very little research into the special ethics of performing studies involving 
pregnant women. Most studies have focused on clinical trials in pregnant women where 
potential physical harm to both the mother and baby has been the main objective 
(McCullough et al. 2005, Helmreich et al. 2007, Wild 2007). However, while other types of 
research not directly related to medical adverse-effects or harm are still meagre, pregnant 
women have been considered as a vulnerable group. Midwives and nurses have an 
important role in recruiting mothers for scientific research (Hicks 1995a, Hicks 1995b, 
McSherry 1997). During recruitment, it is important to appreciate how best to distribute 
facts about the studies so that the mothers and families can make informed decisions and 
acceptance of the responsibility for the outcomes of their choices (Beauchamp & Childress 
2001, ICM International Confederation of Midwives 2012). It is noteworthy that research 
examining the involvement of midwives in scientific biomedical research is scarce and the 
publications that are available mainly investigate the situation existing in the 1990s (Hicks 
1995a, Hicks 1995b, Mc Sherry 1997, Meah et al. 1996). These studies indicated that the 
midwives expressed feelings of lacking sufficient knowledge or the skills to explain 
research as well as the confidence to judge their role in the research (Meah et al. 1996). 
Furthermore, ICM (2012) as well as World Medical Association (WMA 2011) state that 
scientific research should take into account national laws and international guidelines, such 
as the Declaration of Helsinki. There are only a few studies concerning researchers and 
ethical aspects in tissue research (Santa et al. 2007, Campbell et al. 2008). In comparison, 
there has been work done listing the opinions of scientists or medical doctors working in 
genetic research (Hallowell et al. 2009, Ruiz-Canela et al. 2009), clinical trials (Mason et al. 
2000) and clinical settings (Ferguson 2003, Fisher-Jeffes et al. 2007, Hansson et al.  2007).  
The ethical discussion in tissue research has  focused mainly on informed consent 
(Vermeulen et al. 2009 ab, Treweek et al. 2009, Mancini et al. 2011) especially in biobank 
research (Vermeulen et al. 2009 ab, Petrini 2010a). In contrast, although human placenta has 
been used in research rather extensively (Prouillac & Lecoeur 2010) the ethical aspects of 
using placenta have been very rarely discussed (Vawter et al. 2002, Jenkins & Sugarman 
2005, Salvaterra et al. 2006, Lind et al. 2007). One research model involving the placenta is 
placental perfusion (Schneider et al. 1972, Vähäkangas & Myllynen 2006). The aim of the 
human placental perfusion studies in our research group has been to study transplacental 
transfer and placental effects of food carcinogens as a part of an EU project, NewGeneris 
(Contract no. FOOD-CT-2005–0163202). This research program is international and 
multidisciplinary and its objectives are to promote fetal and child health by identifying 
factors in the environment which could be detrimental to the fetus. In these studies, the 
term placenta was collected after the birth from healthy women and the tissue, which 
remained anonymous, was perfused using a well-defined method (Schneider et al. 1972, 
Pienimäki et al. 1995, Annola et al. 2008, Annola et al. 2009) in a university laboratory. 
The ultimate aim of this study was to examine the ethical aspects in tissue research from 
the point of view of different stakeholders. Ethics is an integral component of scientific 
research and it is important to appreciate how the stakeholders in the tissue research 
perceive their participation and the protection of their rights as guaranteed by the ethical 
framework. 
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2 Review of the literature 
2.1 ETHICAL PRINCIPLES IN BIOMEDICAL ETHICS 
2.1.1 Human dignity   
Human dignity can be seen as a core concept in biomedical ethics, being indispensable in 
the moral discourse (Haugen 2010, Jordan 2010, Kotalik 2010). It refers to a collection of 
intangible, distinctively human attributes such as moral virtue, appreciation of beauty, 
awareness of oneself as a unique individual, participation in the human community, 
receptivity and personal agency such as courageous or compassionate (Jordan 2010). 
According to Kotalik (2010), the respect of human dignity is a concept consistent with 
deontologal, natural law, human rights and other ethical theories.  Haugen (2010) also has 
considered dignity as a human rights principle and has insisted that public policy decisions 
need to ensure that they adhere to the goal of upholding human dignity. The value of 
dignity was recognized already in the year 1948 in the United Nations Universal 
Declaration of Human Rights. Article 1 states: “All human beings are born free and equal in 
dignity and rights. They are endowed with reason and conscience and should act towards one 
another in a spirit of brotherhood.” More recently, human dignity has been included up in 
international declarations, for example, the UNESCO (United Nations Educational, 
Scientific and Cultural Organization) International Declaration on Human Genetic Data 
and in the Declaration of Helsinki (Lötjönen 2002, Halila 2007, Haugen 2010). In the 
literature, dignity is also closely linked with integrity and vulnerability (Kottow 2004). 
Attention has also been given to the consideration that dignity is a complex concept 
because it can mean different things to people who are differently situated, for instance, it 
possesses cultural dimensions (De Melo-Martin 2011).  
Macklin (2003a) has claimed that the concept of dignity is useless in medical ethics. 
Macklin (2003a), examined the documents of the international human rights instruments 
and conducted that “dignity” seems to have no meaning beyond what is implied by the 
principle of medical ethics, or respect for persons: the need to obtain voluntary, informed 
consent; the requirement to protect confidentiality; and the need to avoid discrimination 
and abusive practices. In turn, Killmister (2010) has criticized Macklin´s arguments by 
saying that the usefulness of dignity as a guiding principle in medical ethics can be much 
improved by identifying the single conceptual link that ties together the various values 
flying under its banner. This link is based on the concept that dignity is the capacity to live 
by one’s standards and principles. In addition, dignity can play two roles: it is both a 
universal capacity that forms the foundations for the value of human life, thus making it an 
appropriate concept to be included in human rights and bioethics documents in general; 
and it serves to articulate which actions are required for that capacity to be met, in 
particular the absence of humiliation (Killmister 2010). In addition, Haugen (2010) has 
pointed out that dignity applies to everyone in the same way as autonomy or vulnerability, 
but the latter two concepts differ between individuals depending on their abilities, external 
conditions and specific situations.  
The development of biomedical science has been rapid, also in research with human 
tissue, and many questions have been raised during this process e.g. about genetic 
information (Vähäkangas 2004, Vähäkangas 2008, Kirchhoffer & Dierickx 2011, Nuffield 
Council on Bioethics 2011). From an ethical point of view, genetic heritage and genetic data 
can be regarded as unique, and the general understanding is that it differs from other 
health information ( see e.g. UNESCO 2012, Vähäkangas 2008). According to the literature, 
the relationship between human dignity and the use of human tissue does not provide any 
easy answers for biomedical research and practice. Nevertheless, it has been argued that 
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dignity is not a simple criterion and that it is possible to judge which types of treatment of 
human tissue can violate human dignity. Although the majority of research on human 
tissue may not violate human dignity, understanding the moral relevance of where the 
tissue comes from and to what end will it be used make the concept of human dignity 
useful (Kirchhoffer & Dierickx 2011).  
2.1.2 Other ethical principles 
Ethics is about leading a good life, about realizing our dignity and the dignity of others 
(Kirchhoffer & Dierickx 2011). Vähäkangas (2004) has argued that if one accepts that ethics 
can be understood as a reflection of existing moral principles, then the requirements for 
good ethics extend beyond laws and moral principles. In scientific research, this also means 
it is necessary that the scientists improve their personal involvement. Furthermore, if ethics 
are concerned with moral and personal values, it cannot be value-free, and the same 
concept also applies to research ethics.  Ethics can be seen as a reflection of moral principles 
based on the historical perspective and aimed towards the future (Vähäkangas 2004). Most 
ethical theories and traditional medical codes presuppose that there are ethical principles 
and values. A set of principles in a moral code can be seen as an analytical framework that 
expresses the general values underlying rules of common morality. The best known 
principles of bioethics are 1) the respect of autonomy, 2) the principles of beneficence, 3) 
non-maleficence and 4) justice formulated by Beauchamp & Childress already in 1989 (see 
Beauchamp & Childress 2001).  
The critics of these four principles have directed towards the principles themselves, their 
inapplicability in real life and their excessive individualism, i.e. their insistence that people 
are always more important than the values prevailing in their communities (Häyry 2003). 
Consequently, the literature has emphasized the difficulty of demonstrating the concept of 
morality in a concrete manner, as those four principles form a part of a common morality or 
a collection of very general norms (Herissone-Kelly 2011). The principles have also been 
difficult to apply to problems involving certain societal issues e.g. biobanking (Nilstung & 
Hermeren 2006). Rendtorff (2002) argued that ethical principles cannot be understood as 
universal everlasting ideas or transcendental truths but they rather function as reflective 
guidelines and important values in European culture. Rendtorff & Kemp with coworkers 
identified four European ethical principles: respect for autonomy, dignity, integrity and 
vulnerability. The justification for these principles was seen in the fact that they have been 
implemented in legislations throughout Europe, e.g. Constitution of Finland, and take 
better account of vulnerable individuals (Rendtorff 2002, Ebbesen & Pedersen 2007, 2008). 
In addition, the Belmont report (1979) prepared by the U.S. National Institutes of Health 
(NIH) identified the essential ethical principles as follows: respect for persons, beneficence 
and justice. The principle of respect for persons can thus be divided into two separate moral 
requirements: the requirement to acknowledge autonomy and the requirement to protect 
those with diminished autonomy. In scientific research, this kind of respect for persons is 
ensured when adequate standards for informed consent are satisfied (NIH, 1979).   
However, the rapid development of science has triggered criticism towards these basic 
principles (Ebbesen 2009) especially in human tissue research (Hansson 2010). Ebbesen 
(2009) pointed out that difference between different definitions of the principles stem from 
the views of the authors about human nature and their philosophical and cultural 
backgrounds. Furthermore, Launis (2001) raised the issue of whether coherentism can 
provide the best guidance for moral justification in modern biotechnology because there is 
a lack of objective moral values. In addition, moral principles play a dual role in bioethics 
not only serving as normative guidelines but also representing the source of moral theory 
(Launis 2001). It has also been argued in the literature that the existing principles might be 
too narrow (Ijsselmuiden et al. 2010) and restrict the advance of medical knowledge 
(Schaefer et al 2009, Hansson 2010). Ijsselmuiden & coworkers (2010) anticipated that in the 
future, research ethics will involve an intensification of the focus of the role of research in 
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achieving global justice. They devised three values based on their hopes about the future 
development of ethical consideration: solidarity, respect for Southern innovation and 
commitment of action. Hansson (2010) argued that a narrow view of autonomy could even 
harm the interest of patients. Furthermore, Schaefer and coworkers (2009) pointed out that 
participation in research is a critical way to support an important public good, and 
consequently, all individuals have a duty to participate.  
The Nuffield Council on Bioethics (2011) considered what ethical values influenced 
research with human tissue. It is notable that they included, in addition to autonomy and 
justice, also altruism, dignity, maximizing health and welfare, reciprocity and solidarity as 
ethical values. According to Vähäkangas (2011) the principles can also be regarded from the 
point of view of either the individual or at the population/global level. The relevant 
principles on the individual level are beneficence and non-maleficence, justice, autonomy 
and confidentiality, whereas the population or global level principles are: equality, 
solidarity, benefit sharing, global justice, cultural pluralism and responsibility. Lev (2011) 
also stated that solidarity, equality, personal responsibility and autonomy were valuable 
principles which should not be jeopardized in the context of biomedicine.  
Despite the fact that different opinions about ethical principles and their suitability for 
biomedical research have been introduced, there is some uniformity in these definitions. 
Autonomy, including informed consent, has been adopted as a central concept in 
biomedical ethics by many authors (e.g. Beauchamp & Childress 2001, Rendtorff 2002, Lev 
2011). In addition, privacy as a concept is closely linked with integrity and autonomy 
(Ursin 2010) but also with confidentiality (CDBI, Steering Committee of Bioethics 2011, 
Vähäkangas 2011) and integrity (Beauchamp & Childress 2001). Again, in the literature, 
justice is seen as the basic principle ensuring fairness and equity, vulnerability as well as 
solidarity (Rawls 1971, NIH 1979, Beauchamp & Childress 2001, Ijsselmuiden et al. 2010, 
Rogers & Kelly 2011, Lev 2011). Beneficence and non-maleficence as principles have been 
important part of medical ethics since the Hippocrates Oath, “Do no harm”, and can be 
regarded as still applicable today (Beauchamp & Childress 2001, NIH 1979, Ebbesen 2009).   
 2.1.3 Autonomy, privacy and voluntariness 
Autonomy, including informed consent, has been adopted as a central concept in 
biomedical ethics by many authors. Autonomy includes liberty, privacy, self-governance 
(Beauchamp & Childress 2001) is based on morality and human dignity and includes 
aspects of integrity and vulnerability (Jordan 2010). Respect for the autonomous choices of 
an individual is a common moral principle, which has also been discussed in medical ethics 
in clinical settings from the point of view of patients (Gonen 2002, Hunt & de Voogd 2007, 
Nyrhinen 2007, Falagas et al. 2009, Rahman et al. 2011, Will 2011a,b) doctors (Fisher-Jeffes 
et al. 2007, Will 2011a,b) and nurses (Lee et al. 2009). Respect for autonomy is seen as the 
norm i.e. one must of respect the decision-making capacities of autonomous persons 
(Beauchamp & Childress 2001). Alternatively, O´Neill (2002) states that, a physician´s 
primary obligation is to act the best interest of the patient e.g. in emergency situations (see 
e.g. Halila 2007).  
Autonomous action is an action to which people consent as free and equal rational 
beings, and they are to be understood in this way. A well-ordered society affirms the 
autonomy of persons and encourages them in making objective judgements of justice.  
(Rawls 1971). The concepts of autonomy and informed consent are also enshrined in the 
most important international guidelines (e.g. Declaration of Helsinki, ICH- Good Clinical 
Practice, CIOMS) and national legislation (Constitution of Finland, Medical Research Act, 
Act of Medical Use of Human Organs and Tissues). According to Haugen (2010), autonomy 
can be understood to embrace non-discrimination, participation, empowerment, rule of law 
and accountability. In addition, autonomy can be viewed as being embedded in the concept 
of human dignity (Haugen 2010).  
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In research, the principle of autonomy can be assessed through the process of free and 
informed consent. Although medical practice is expected to confer a health benefit for the 
patient, the nature of research means there is uncertainty about whether the participants 
will actually benefit from research participation and these kinds of benefits are not the main 
purpose of the research. Participants must be provided with appropriate, accurate and 
understandable information about the research before asking them to choose whether or 
not they wish to participate. In the context of biomedical research, an individual should be 
provided with the necessary conditions to exercise his or her autonomy, and a person 
whose autonomy is diminished or impaired needs to be protected from harm and abuse 
(Beauchamp & Childress 2001, Vähäkangas 2004, Hunter 2006, WMA 2011).  
Privacy is closely connected with autonomy as well as human dignity and respect for the 
individual (Eriksson & Helgesson 2005a, Heikkinen 2007, Ursin 2010, Tännsjö 2011). 
Additionally, the concept of privacy is complex and involves different perspectives and 
dimensions; there is no single universal definition of privacy (Leino-Kilpi et al. 2001, Ursin 
2010). The dimensions of the concept of privacy have been described through the concepts 
of physical, psychological, social and informational privacy. Furthermore, earlier studies 
clearly highlighted the importance of the concept of privacy in hospital organisations and 
have considered also the problems of implementation. The most common problems have to 
do with noise, limited space and restrictions. In addition, informational privacy is often 
concerned with the confidentiality of patient information (Leino-Kilpi et al. 2001, Schmidt et 
al. 2009, Casteleyn et al. 2010, Ursin 2010) and especially in tissue research with respect to 
personal genetic information (Hull et al. 2008, Tännsjö 2011, Ursin 2010). Public confidence 
in the use of health research data is essential (Kapp 2006) and it is important to develop 
good research governance, this has been stated to be in the interests of all stakeholders in 
research (van Veen 2008, Schmidt et al. 2009). According to Jackson & Lim (2011) there is a 
need for education to improve knowledge and practice of confidential data handling. The 
ethical point of view, this aspect is bound to take on increasing importance in the future 
with the continuing growth of scientific research (see e.g. Leino-Kilpi et al. 2001, Jackson & 
Lim 2011, Tännsjö 2011).  
Similarly, voluntariness is emphasized as a part of autonomy, meaning that free and 
informed consent also implies that participants must not be coerced or unduly influenced. 
Undue influence may be financial in nature or, for instance, an attempt to influence close 
relatives (Beauchamp & Childress 2001, Vähäkangas 2004, CDBI 2011, WMA 2011). 
Nevertheless, the focus should not lie solely on the disclosure of information or decision-
making but also on the effective communication and commitment between the parties 
involved in the research (Manson & O´Neil 2007, Sutrop 2011). There has also been 
speculation about whether the protection of individuals has gone too far and whether the 
need to achieve of autonomy and privacy has become an obstacle to research. As early as 
1997, Van Damme and co-workers (1997) postulated that a broader consent in the context of 
genetic screening and genetic monitoring should be considered. The current discussion is 
also shifting from individual rights towards the common good, and it has been claimed that 
the form of informed consent and autonomy should be reconsidered, especially in human 
tissue research (Siegel et. al 2009, Sutrop 2011).   
2.1.4 Justice and solidarity 
Questions of justice have usually been associated with social practices such as punishment, 
taxation and political representation. In the year 1971, John Rawls introduced two 
principles of justice. According to the first principle, each person is to have an equal right to 
the most extensive basic liberties compatible with a similar liberty for others, and the 
second principle holds that, social and economic inequalities are to be arranged so that they 
are both (a) reasonably expected to be in everyone´s advantage and (b) attached to positions 
and offices open to all. Positive discrimination can be acceptable if it confers the greatest 
benefit to those worse off (Rawls 1971). Justice has been generally defined in relation to 
7 
 
 
biomedicine, but it also has relevance for research. The principle of justice can be 
considered as fairness and equity. One crucial question is who ought to receive the benefits 
of research and who should bear its risk and burden. In biomedical research involving 
human beings, this implies that the distribution of risk and burden on the one hand and 
benefit on the other has to be fair a principle known as distributive justice. Distributive 
justice carries with it implications especially for the selection of research participants: the 
selection criteria should be related to the purpose of the research (NIH 1979, Beauchamp & 
Childress 2001, CDBI 2011).  
Justice cannot be viewed only as the protection of participants in health research but also 
as the broadening of peoples thinking in the social context of individuals´ lives by 
considering the complex influence of social differences and power relationships within the 
research process. Health research can be seen as an activity that promotes social justice 
(Rogers & Kelly 2011). In addition, it has been proposed that the ethics review should be 
expanded to consider wider health and socio-economical benefits, including intellectual 
property rights, technology transfer, institutional capacity strengthening as well as finding 
other ways of sharing the benefits of research (Ijsselmuiden et al. 2010). The focus should be 
on responsible research with considerations of the needs of the developing countries 
(Ijesselmuiden & Jacobs 2005, Ijsselmuiden et al. 2008, London & Kimmelman 2008, Matlin 
et al. 2008, Sewankambo & Ijsselmuiden 2008) and patients with limited language skills 
(Bhutta 2004, Casteleyn et al. 2010, Glickman et al. 2011) as well as tissue exportation from 
the developing countries to the developed world (Upshur et al. 2007, Andanda 2008, Zhang 
et al. 2010).   
The selection of research subjects needs to be scrutinized in order to determine whether 
some groups (e.g. welfare patients, particular racial and ethnic minorities, or persons 
confined to institutions) are being systematically selected because of their ready 
availability, their compromised position, or their manipulability, rather than for reasons 
directly related to the problem being studied (NIH 1979). One could consider the opposite 
case, whether a certain group is being systematically ignored, because of the difficulties to 
obtain informed consent or other reasons (Glickman et al. 2011, Iltis 2011). Rawls (1971) 
considered solidarity to have a special role in defining the principle of justice. Solidarity is 
described as a mutual attachment that people have towards each other, giving rise to 
various obligations such as the obligation to help people meet their basic needs. In addition, 
solidarity has also been described by using the following concepts: integration, 
commitment to the common good, empathy and trust (Lev 2011). In genomic research, for 
example, where no immediate clinical benefit is to be expected and where the key question 
is really whether we can be obliged to undertake sacrifices to benefit future patients, justice 
and solidarity can be regarded as the guiding principles (Hoedemaekers et al. 2007).  
Subsidiarity as a principle has been introduced in the literature and this is connected 
closely to justice (Kotalik 2010). It has been found as suitable in the context of biomedical 
ethics (Pennings et al. 2004, Kotalik 2010). Subsidiarity means that matters ought to be 
handled by the smallest, lowest or least centralized competent authority.  This is the only 
principle that addresses the issue of the locus of decision making, and it is strongly linked 
to human dignity, democracy and solidarity. Subsidiarity can be understood as a 
procedural manifestation of relational solidarity. It also supports and enhances human 
dignity by respecting the creativity of humans and because it holds a high regard for the 
freedom of individuals, families, groups and communities. It has been argued that the 
value of the Principle of Subsidiarity is that it can address the question of how and by 
whom decisions should be made in the context of biomedical ethics (Kotalik 2010).  
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2.1.5 Beneficence and non-maleficence – balance of benefits and harm 
For a long time the Hippocratic maxim ”do no harm” has been the central principle for 
medical ethics (NIH 1979, Beauchamp & Childress 2001). The Hippocratic Oath and its 
successors state that physicians have a fundamental medical duty to pursue the patient´s 
best medical interest, to avoid harm and to maintain the patient´s confidence (BMA 2004). 
The principle of beneficence often occupies a well-defined justifying role in many areas of 
research involving human subjects. Research guidelines emphasize that the welfare of the 
research participant must be a primary concern. According to the legislations and 
international guidelines, it is unacceptable to prioritize the expected benefits to society over 
the welfare of individual people (BMA 2004, Medical Research Act, WMA 2011).   
The principles of beneficence and non-maleficence together create a moral obligation to 
maximize potential benefit and minimize potential harm. The principle of beneficence also 
has further implications, in particular that the design of the research studies is sound and 
meets the accepted criteria of scientific quality. This also implies that the researchers are 
competent to carry out the research (Beauchamp & Childress 2001, CDBI 2011). All research 
projects need to undergo a thorough risk/benefit assessment; risk identification, estimation 
and evaluation are all stages in risk assessment. The participants’ overall benefits from the 
research project must clearly be higher than the potential risks (Beauchamp & Childress 
2001). 
 In clinical research, participants should understand the distinctions between usual care 
and research. The absence of this knowledge has been termed as the therapeutic 
misconception (Lidz et al. 2004, Miller & Joffe 2006, Appelbaum & Lidz 2006). Pelias (2004) 
pointed out that in tissue research, and especially research in human genetics, the 
researcher should consider the tensions between doing no harm to the participant and the 
participant’s personal autonomy. These tensions arise from the question of whether the 
participants will have the right to see their own results, the accuracy of which may not be 
guaranteed. Eriksson & Helgesson (2005b) have also brought up the concept of moral harm 
in the use of tissue samples for future use.  For example, moral harm could be created when 
samples would be used for research to which participants would strongly object.  
2.2 REGULATIONS CONCERNING TISSUE RESEARCH IN FINLAND  
2.2.1 Application of international guidelines nationally 
In biomedical research, human tissues are a valuable resource, but their use also carry 
ethical (Vähäkangas 2004, Cambell et al. 2008) and legal considerations (Campbell et al. 
2008, VanVeen 2008). Many international regulations have been drafted based on national 
legislations. In the Convention for the Protection of Human Rights and Fundamental 
Freedoms, ratified in Finland in May 1999 (63/1999) and the EU member states have agreed 
to support the Universal Declaration of Human Rights proclaimed by the General 
Assembly of the United Nations on the 10th of December 1948. These international 
declarations of human rights and ethical principles form the basis for national and 
international regulations.  
In addition to national legislation, there are several international guidelines and 
recommendations (table 1) that have important roles in advancing international discussion, 
interpreting and amending legal instruments and serving as grounds for judicial decisions 
when legislation is not comprehensive (Lötjönen 2004). The World Medical Association 
(WMA) has developed the Declaration of Helsinki as a statement of ethical principles for 
medical research involving human subjects, including research on identifiable human 
material and data. The Declaration was first adopted in 1964 and it has been amended eight 
times since that date, most recently in 2008 when research on identifiable human material 
and data was included in the declaration. The declaration provides guidelines for 
recruitment, the informed consent process as well as for balancing the risks and benefits. 
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Confidentiality and aspects concerned with the scientists’ skills and the ethics review are 
also included. The declaration states that the physician must make an effort to gain consent 
for collecting, researching, storing and reusing samples. If consent from the tissue donor is 
difficult to obtain or this difficulty threatens the quality of the research, then the ethical 
committee can also grant permission for the research without the donor’s consent (WMA 
2011), which is in contravention of Finnish legislation, e.g. Finnish Act of Medical Use of 
Human Organs and Tissues (see table 2). In addition to the Declaration of Helsinki, some 
well-known examples include the CIOMS (Council for International Organization of 
Medical Sciences) and ICH-GCP (International Conference on Harmonisation - Good 
Clinical Practice) guidelines, the latter of which was used as a reference when preparing the 
European Union Clinical Trials Directive (Lötjönen 2004).  
CIOMS (Council for International Organization of Medical Sciences) in collaboration 
with WHO (World Health Organization) has published the International Ethical Guidelines 
for Epidemiological Studies (2008) concerning research with stored biological samples and 
related subjects for future epidemiological research. According to Guideline 24, an 
investigator in this field must obtain the voluntary informed consent of the individual 
donor. If the individual is not capable of giving an informed consent, the permission should 
be obtained from the legally authorized representative of the donor in accordance with 
applicable law. The research proposal must also be submitted to an ethical review 
committee. If the stored samples had been collected for a past research, clinical or other 
purposes without informed consent, the ethical review committee may consider waiving 
the consent if it proves materially unfeasible to obtain consent. The 2009 amendment of 
CIOMS concerning informed consent states that, with certain conditions, the ethics 
committee may consider whether new consent is needed for work involving the use of old 
samples (CIOMS 2011).   
Both the Declaration of Helsinki and CIOMS emphasize the importance of voluntary 
informed consent. However, these guidelines also pay particular attention to tissue research 
and the difficulties in obtaining consent. A special status is given to the ethics committee 
and the review process. This has been taken into account in the Finnish Government bill on 
biobanks, where much attention has been paid to the review process in accordance with 
both guidelines. 
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Table 1.  Some useful sites on medical bioethics including human tissue research 
 
Organization Content includes Internet address 
World Medical 
Association, 
WMA 
 
Declaration of Helsinki.  Ethical Principles for 
Medical Research Involving Human Subject 
www.wma.net 
Council for 
International 
Organizational of 
medical sciences, 
CIOMS 
 
International Ethical Guidelines for Biomedical 
Research Involving Human Subjects 
www.cioms.ch. 
UNESCO International Declaration on Human Genetic 
Data 
 
www.unesco.org 
Council of Europe, 
Steering 
Committee on 
Bioethics (CDBI) 
Purpose is to protect human rights and dignity 
in the field of biomedical research. Its purpose 
is to define and safeguard fundamental rights 
in biomedical research, in particular of those 
participating in research. 
 
http://www.coe.int/t/dg3/ 
healthbioethic/cdbi/ 
INF_2011_%201%20E%20info 
%20doc%20cdbi.pdf 
Nuffield Council on 
Bioethics 
An ethical and legal framework for the use 
human tissue  
 
http://www.nuffieldbioethics.org 
Nordic Committee 
on Bioethics 
Identify and survey ethical issues related to 
legislation, research and developments in 
biotechnology in the Nordic countries and 
internationally. 
www.norden.org 
 
 
2.2.2 Ethical aspects in legislation in Finland 
In Finland, the basis for the rights and liberties of people are established in the Constitution 
of Finland (731/1999). The Constitution is also an important Act concerning medical ethics 
and its principles (Lötjönen 2004).  According to the Constitution of Finland, everyone is 
equal before the law and no one shall, without an acceptable reason, be treated differently 
from other persons on the ground of sex, age, origin, language, religion, conviction, 
opinion, health, disability or other reason that concerns his or her person. The Act also 
contains aspects about children, stating that children shall be treated equally and as 
individuals, and they shall be allowed to influence on matters pertaining to them to a 
degree corresponding to their level of development (Constitution of Finland).  
Research utilizing human tissues is firmly regulated by Finnish national legislation: 
Medical Research Act (488/1999, 295/2004, 794/2010) and Act of Medical Use of Human 
Organs and Tissues (101/2001, 547/2007, 778/2009, 653/2010) as well as Personal Data Act. 
Privacy and handling confidentiality of personal information are also included in the Act 
on the Status and Rights of Patients (785/1992) and The Act on The Openness of 
Government Activities (621/1999) (see table 2 more detailed content.).    
The most important Act concerning medical research in Finland is the Medical Research 
Act, which states that research conducted under this act shall respect the inviolability of 
human dignity. The Medical Research Act came into force in 1999 with amendments 
appearing in 2004 (295/2004) and 2010 (729/2010). The Act defines medical research as 
research involving intervention in the integrity of a person, human embryo or human 
foetus for the purpose of increasing knowledge of health, the causes, symptoms, diagnosis, 
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treatment and prevention of diseases or the nature of diseases in general. In 2010, an 
amendment (729/2010) extended the coverage of this Act to cover other areas of health 
research which may violate human integrity (Medical research Act, Halkoaho et al. 2010, 
Keränen et al. 2011). The Medical Research Act also regulates how the ethical pre-
evaluation is to be done by independent ethics committees. In addition, the risks and 
benefits of the research must be considered carefully. Furthermore, the Medical Research 
Act emphasizes the participants’ personal autonomy and informed consent and considers 
the position of vulnerable groups. According to the law, medical research cannot be 
conducted without the research subject’s informed consent. The Medical Research Act does 
not define human tissue research in detail.  
The Act of the Medical Use of Human Organs and Tissues (101/2001, 547/2007, 778/2009, 
653/2010) regulates the medical use of human organs, tissues and cells, as well as how to 
consider the change to which the tissue samples are being put in medicine and medical 
research. The Act describes different possibilities to use tissue in research and is concerned 
with entire consent procedures i.e. from obtaining informed consent from the subject up to 
authority permission. According to this Act, human tissues and cells are defined as follows: 
all tissues and cells taken from humans for a specific research use, including 
haematopoietic stem cells from peripheral blood circulation, umbilical cord and bone 
marrow, gametes, fetal tissues and cells, as well as adult and embryonic stem cells. This law 
has been amended three times since its enactment when the European Union Commission 
Directives 2004/23/EC, 2006/17/EC, 2006/86/EC concerning e.g. standards of quality and 
safety for donation human tissues and cells (not concerned with research, e.g. in vitro 
research or animal models, using human tissues and cells) were included in the act (Act of 
the Medical Use of Human Organs and Tissues). 
The objectives of the Personal Data Act (523/1999) are to implement, the aspects of 
privacy and handling confidentiality in scientific research. It also highlights the details of 
personal data which are: 1) any information on a private individual or the members of 
his/her family or household, and 2) their personal characteristics or personal circumstances, 
where these are identifiable as concerning this data (The Personal Data Act). A human 
sample does not fulfill the definition of personal data, because a sample itself does not 
contain information related to the person. However, when linked to information related to 
the person, a sample can become a part of his/her personal data. If the sample cannot be 
identified as belonging to a certain individual, the Personal Data Act cannot be applied. 
Nonetheless, confidentiality and privacy will play a major role in the forthcoming Finnish 
Biobank Act (HE 86/2011).  
A national regulation (117/2010) has also enforced a convention for the protection of 
Human Rights and the dignity of the human being with regard to the application of biology 
and medicine: The Convention on Human Rights and Biomedicine. The parties to this 
Convention shall protect the dignity and identity of all human beings and guarantee 
everyone, without discrimination, respect for their integrity and other rights and 
fundamental freedoms with regard to the application of biology and medicine. The 
interests and welfare of the human being shall prevail over the sole interest of society or 
science. An intervention in the health field may only be carried out after the person 
concerned has provided free and informed consent to be a part of this research. This person 
shall beforehand be given appropriate information about the purpose and nature of the 
intervention as well as its consequences and risks. The person concerned may freely 
withdraw his or her consent at any time (Convention on Human Rights and Biomedicine 
2011). These laws address several ethical aspects concerning human tissue research: the 
ethical review process, avoiding harm, confidentiality of personal information, and the 
informed consent process. Nevertheless, it is also apparent that some societal aspects are 
missing such as how to consider tissues being stored in a biobank research as well as a 
population and global perspective.  
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Table 2. Relevant legislation and content concerning tissue research in Finland (www.finlex.fi)  
  
Regulations Main content Ethical aspects 
Constitution 
of Finland 
Everyone has the right to life, personal liberty, integrity and security. 
The right to privacy, which also includes one’s right to freely control oneself 
and one’s body. 
 
Human dignity, 
integrity, privacy, 
equality  
Medical 
Research Act 
(488/1999, 
/2004,/2010) 
Regulate Medical Research:  
 The scope, definition  and general conditions governing medical 
research 
 People in charge of research 
 Regional and national ethics committees 
 Weighing up benefits and harmful effects 
 Informed consent (form, from and whom), possibility to withdrawn 
consent  
 Research involving persons not able to consent, minors, pregnant 
women and nursing mothers, prisoners or forensic patients 
 Define clinical trials on medicinal products, good clinical research 
practice 
 Define research involving embryos and fetuses 
 
 
 
 
 
Ethics committee 
review process, 
avoiding harm, 
informed consent 
process, 
vulnerability 
 
Finnish Act of 
Medical Use of 
Human 
Organs and 
Tissues 
(101/2001, 
547/2007, 
778/2009, 
653/2010) 
 
Regulate as follows the use of tissue sample when change in purpose for which 
tissue samples will be used: 
 Taken for therapeutic or diagnostic purposes: the patient’s consent or 
his/her legal representative’s permission. National Supervisory 
Authority for Welfare and Health (Valvira) can give permission for the 
surrender or use of tissue samples taken for therapeutic or diagnostic 
purposes or to establish the cause of death in situations in which the 
person’s consent is impossible to obtain.  
 Taken for medical research purposes may be surrendered and used for 
medical research other than that stated in the consent document only 
with the consent of the person concerned. If the said person has died, 
Valvira can give permission for such research if justifiable cause 
exists. 
 Taken for therapeutic or diagnostic purposes, or to establish the cause 
of death may be surrendered and used for medical research and 
teaching purposes with permission from the health care unit or other 
unit for whose activities the sample was taken without personal data.  
 
Informed consent, 
privacy 
Personal Data 
Act 
(523/1999) 
 
Regulate the processing of personal data, the protection of private life and the 
other basic rights which safeguard the right to privacy, to promote the 
development of and compliance with good processing practice. Personal data 
may be processed for purposes of historical or scientific research for a reason. 
Privacy and 
handling 
confidentiality of 
personal 
information.  
 
The Act on the 
Status and 
Rights of 
Patients 
(785/1992) 
Everyone living permanently in Finland, without discrimination, have the right 
to health care and medical treatment. The treatment must be organized in a 
way that does not violate the person’s human dignity and respects his/her 
personal conviction and privacy.  
Defines also the basic principles of preserving samples and models taken 
during therapy. 
 
Human dignity, 
privacy, 
confidentiality 
The Act on the 
Openness of 
Government 
Activities 
(621/1999) 
Regulates on the right to obtain information from public documents of the 
authorities and on the authorities’ professional discretion.  
A sample of human origin does not constitute a document defined in the act; 
however, a sample may be part of the document when the sample or 
information about the sample is attached to the document describing or 
defining the sample. 
 
Confidentiality 
and privacy 
Act of Biopank 
Goverment 
bill 89/2011 
(under 
consideration 
by the 
parliament) 
Will include the following topics: 
 Ethical review process 
 Structure of the biobank 
 Management issues 
 Consent (form, from whom) 
 Information about the use of tissue sample, source of information  and 
check-up possibility  
 Withdrawal 
Informed consent 
process, 
confidentiality and  
privacy 
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2.2.3 Ethics committee review process 
In most countries, the majority projects in health research, including tissue research, 
involving human participants is reviewed by a Research Ethics Committee (REC). Within 
the European Union, this is legally mandatory for all clinical trials with medicinal products 
for human use. In addition, many countries require similar levels of review for all medical 
research (Lötjönen 2004, Hedgecoe et al. 2006, Klitzman 2011). In addition, there may be 
some practical reason for the review process e.g. requirements of medical journals (ICMJE 
2012).    
Internationally, there has been discussion about the number of ethics committees 
(Wainwright & Saunders 2004, Klizman 2011) and whether all medical studies need to be 
reviewed e.g. non-invasive studies (see e.g. Hearnshaw 2004). This has also been an agenda 
in Finland (Halila 2009). In 2009 Halila (2009) highlighted the fact that the current situation 
might benefit from reducing the number of research ethics committees, since this could lead 
to more experienced members and higher-quality reviewers. In Finland, the Medical 
Research Act amendment in 2010 actually reduced the number of ethics committees (Halila 
2009, Keränen et al. 2011) and focused on the competence of the members (Keränen et al. 
2011).  
Research ethics committees are constituted and function in various different ways. In 
some countries, the ethics committees may be linked to public health or research 
institutions as well as to hospitals. In addition, most countries have local and central or 
national committees (Wainwright & Saunders 2004, Hedgecoe et al. 2006, Moerman et al. 
2007, Halila 2009, EU 2011, Klitzman 2011). However, there are several principles that have 
to be followed to ensure that the committees are competent to perform the task assigned to 
them. The most important principle is independence in order to avoid conflicts of interest. 
In addition, ethical and scientific expertise is needed to be able to review protocols, as well 
as a degree of diversity among the members chosen to represent the general public. (EU 
2010). Ethics committees weigh ethical aspects against national regulations (Casteleyn et al. 
2010, Holm 2011) and against ethical principles. Criticism has been expressed that the ethics 
committees are too bureaucratic (Spence 2011) or too strict (Hansson 2010) or the process 
takes too long (Keinonen et al. 2003). In addition to the above criticisms, Casteleyn and 
coworkers (2010) have listed some aspects that have been brought up in the literature such 
as organizational aspects, lack of diversity in opinions that are represented and professional 
competence of the members of ethics committees (Casteleyn et al. 2010). Furthermore, some 
critics have highlighted the question of gender equality among committee members 
(Dickenson 2006, Moerman et al 2007).   
Nevertheless, Edwards and co-workers (2004) pointed out that differences between the 
judgments of ethics committees may not be problematic. They also insisted that consistency 
of the ethics committee as a regulatory or governance process will never achieve perfection. 
Holm (2011) has argued that self-regulation by scientists themselves is not sufficient to 
achieve an ethically acceptable balance of the different interests that may be at stake. He 
recognized that strict conformity to ethical rules may not be desirable, but there seems to be 
no better alternative than the current system of ethics review boards (Holm 2011). Good 
communication between the scientists and the ethics committee is critical in order to 
guarantee a thorough handling of all ethical aspects of research and in this way to ensure 
protection of research participants and the scientists i.e. preventing mishandling of their 
study and patients (Vähäkangas 2004, Ylitalo 2006, Taylor et al. 2008, Merlo et al. 2007). It is 
arguable that despite the criticism that has been leveled against the ethics committee review 
process, independent ethics committees also have their advocates in the literature. 
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2.2.4 Avoiding harm and confidentiality of personal information 
One of the most important ethical aspects in biomedical research is avoiding harm. It is 
generally accepted in laws and guidelines that research subjects may be exposed only to 
measures where the expected health or scientific benefits are unequivocally greater than the 
potential risks or harm to the research subject (The Medical Research Act, WMA 2011). 
Avoiding harm and risk has been highlighted in the literature which has been concerned 
with the legislation (Miller & Joffe 2009, Rid et al. 2010) although but not overlooking the 
possibility of overprotection of the participants (Miller & Joffe 2009).  However, Van Ness 
(2001) criticized use of the concept of risk in biomedical research. His perception was that 
risk infers the possibility of harm. The concept of harm is clearly unintended and 
undesirable in biomedical research projects. Therefore, when using the concept of risk, 
ethical vigilance is required e.g. thoughtful planning of clinical trials taking into account 
both ethical aspects and methodological considerations (Van Ness 2001).  
In medical ethics, a boundary has been drawn between clinical research and clinical 
medicine and the putative research participant should understand the difference between 
research and care, the so-called therapeutic misconception (Lidz et al. 2004, Miller & Joffe 
2006, Appelbaum & Lidz 2006). For instance, research participants may sign the consent to 
participate in a clinical research with only a modest appreciation of the risk or the 
disadvantages of participation (Appelbaum & Lidz 2006). However, it has been questioned 
whether integration between care and research can provide better care and would thus be 
ethically achievable (Beauchamp 2011, Hansson & Chadwick 2011, Largent et al. 2011). 
Even though it is accepted that integration may provide better care to the patients, the 
general opinion is that research participants should be aware of the difference between care 
and research and that this kind of information must be provided in a comprehensible 
manner.  
Using left-over samples of from diagnostic and therapeutic procedures and their 
subsequent use in research is common in clinical settings. However, it is necessary to 
discuss whether this kind of research causes harm to the participants and whether any 
informed consent is needed (Kapp 2006). However, the question of whether the sample 
should be large enough for both clinical care and research has been rarely discussed. This 
raises an ethical question, especially in research with children (see e.g. Reid 1994). The Act 
of the Medical Use of Human Organs and Tissues (101/2001) states that, using samples in 
research must not hamper the use for, which they were originally intended. Moreover, the 
risk of harm caused by tissue research has also been connected with genetic research, from 
the point of view of privacy and confidentiality (Goodson & Vernon 2004) and the 
invasiveness of the procedures (Gillet 2007, Vähäkangas 2008).  
In the Belmont report, vulnerability was linked to the selection of subjects. Macklin 
(2003b) describes vulnerability as referring to instances when an individual or groups are 
subject to exploitation.  In addition, regulations and policy documents provide some focus 
on the limitations of an individual´s capacity to provide informed consent (Levine et al 
2004). Vulnerability is also seen as one of the ethical principles by Rendtorff & Kemp 
(Rendtorff 2002), and in the literature, being at the core of human rights (Haugen 2010). 
Particular attention is paid in the literature to the most vulnerable groups e.g. children (Iltis 
2009, Haugen 2010). However, according to the literature, it is not always clear who is 
vulnerable, even though vulnerability has been a prominent aspect in the research ethics 
literature and the regulations concerning human research (Coleman 2009). Vulnerability 
typically has been understood in terms of the ability to give or withhold informed consent 
and the likelihood of being mislead, mistreated or otherwise taken advantage of in the 
research. A criticism has been expressed for designating as vulnerable groups, those who 
are seriously ill (cancer patients), terminally ill patients and minors (Hurst 2008, Iltis 2009).   
Iltis (2009) pointed out that some authors have argued that the categories of people now 
being considered as vulnerable are so diverse that virtually all potential human subjects 
could be included. Lev (2011) pointed out that when children are considered as a 
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vulnerable group, biomedical progress might be problematic. This question can arise with 
new innovations, especially in genetic research when parents consent on behalf of their 
children.   
Confidentiality can be regarded a special case of privacy protection in tissue research as 
well as other biomedical research. It is evident that anyone who has access to someone’s 
personal information has a duty not to pass on that information to outsiders or to use it for 
ends other than those agreed upon. In this sense, confidentiality could be viewed as making 
it an ethical and legal duty of the individual or group which has gained access to the 
information to keep it confidential (see e.g. Ursin 2010). In tissue research, confidentiality 
has been viewed as a high priority among ethical aspects because of the possibility to access 
genetic information (see e.g. Vähäkangas 2008).  In confidentiality, the key ethical and legal 
issue is not only whether study participants are adequately and equally protected but 
whether, at the same time, scientific progress is being safeguarded (Casteleyn et al. 2010). In 
tissue research, confidentiality also depends on whether samples are identifiable, coded, 
encrypted or anonymous (Goodson & Vernon 2004, Kapp 2006, Vähäkangas 2008, Schmidt 
et al. 2009). In the literature, the terminology about labeling samples varies and sometimes 
causes confusion (Vähäkangas 2004, Vähäkangas 2008). Patients may be anxious to know 
whether their samples will be used for further purposes either identifiably or anonymously 
(Hull et al. 2008, Tupasela et al. 2010) and whether their consent also includes providing 
access to their personal clinical data (Mancini et al. 2011). Moreover, public opinions may 
differ on whether sponsorship involves domestic or international sources (Hemminki et al. 
2009). The discussions about harm and confidentiality have stressed the importance of 
continuing the research and discussion of ethical aspects in tissue research.   
2.2.5 Informed consent process 
Informed consent to research derives from a legal doctrine and it comprises three elements: 
Relevant information is provided to a person who is competent to make a decision and who is 
acting voluntarily (Beauchamp & Childress 2001, Vähäkangas 2004, Appelbaum et al. 2009, 
WMA 2011).  Beauchamp & Childress (2001) have introduced elements of informed 
consent: 1) Threshold elements are competence and voluntariness. 2) Information elements 
are material information, recommendation of a plan and understanding. 3) Consent 
elements are decision and authorization of the chosen plan. Similarly, according to the 
Belmont, report there is a widespread agreement that the consent process can be considered 
as containing three elements: information, comprehension and voluntariness (NIH 1979). 
Hence, the participation in any study requires that the participants are fully competent to 
give consent for their participation. The consent must be a voluntary choice, and as a basis 
of this choice, the participants to have information presented to them in a manner they can 
comprehend. After this, the putative participant can make his or her own choice to 
participate and thus authorise the research staff to act according to the plan (Beauchamp & 
Childress 2001, Vähäkangas 2004).  
There are many studies about informed consent  in research  e.g. in neonatal research 
(Mason et al. 2000), healthy voluntary participants (Kass et al. 2007, Länsimies-Antikainen 
et al. 2007, 2010a,b), emergency research (Halila 2007, Parvizi et al. 2008) and clinical 
settings (Wendler & Grady 2008). According to the literature, major future challenges 
include the consent for future biobank storage and unforeseen future research (Hansson et 
al. 2006, Hofmann 2009, Secko et al. 2009, Toccaceli et al. 2009) and interpretations of the 
concept of autonomy and informed consent in different cultures (Bhutta 2004, Casteleyn et 
al. 2010). The Medical Research Act states that information about research must be given so 
that research subjects are in a position to provide informed consent. This has been 
recognized in the literature: the importance and challenging nature of the timing of the 
consent has been stated as important (Vähäkangas 2004, Cahana & Hurst 2008, Hewitt et al. 
2009) and the different kinds of procedures to obtain genuine informed consent have been 
claimed to require a rethinking (Hamilton et al. 2007, Cahana & Hurst 2008, Schwartz & 
16 
 
 
Appelbaum 2008, Hofmann 2009, Hewitt et al. 2009, Wendler 2011). It is known also that 
understanding of research information is limited in research participants (Crepeau et al. 
2011, Desch et al. 2011, Monson et al. 2012) and different types of presentations of 
information are needed (Monson et al. 2012).  
Cases of potentially impaired voluntariness have also been raised as an issue in 
numerous contexts: compensation for entering a research study, recruiter being the 
subject´s own physician, drug abuse of participants, patient’s lack of other access to medical 
care and coercion by some person in a position of authority, e.g. husband or tribal leader. 
However, according to the literature, the presence of influence does not mean that the 
decision is not voluntary. The decision becomes involuntary if it is subject to a particular 
type of influence that is external, intentional, illegitimate and causally linked to the choice 
of the subject (Appelbaum et al.  2009).  
Informed consent may have a different meaning in different types of human tissue 
research. For instance, it has been discussed whether the use of archived pathology samples 
or human tissue samples given anonymously requires any specific informed consent (Kass 
et al. 2007, Bathe & McGuire 2009).  Vermeulen & coworkes (2009a, b) in their studies have 
aimed to determine the procedure by which patients can influence the use of their samples 
for research purposes. The majority of the patients preferred the “opt-out plus consent” 
procedure where individuals are actively informed (verbally and by means of a leaflet) 
about the possibility to opt-out of all future research being done with their tissues. 
Particularly in biobank and epidemiological research, a broad type of consent has been 
raised as one possibility (Aromaa et al. 2003, Hansson et al. 2007, Stjernschantz Forsberg et 
al. 2009, 2010, 2011). The prerequisite for broad consent is that there is public education and 
debate on issues such as the necessity of research, the risks involved, and the safeguards 
that society has put in place to protect both individuals and groups of people against harm 
(Vähäkangas 2004, Hansson et al. 2007, Stjernschantz Forsberg et al. 2009, 2010, 2011). In 
comparison, Nuffield Council on Bioethics (2011) recommended that when a patient 
consents to medical treatment involving the removal of tissue, that consent should be taken 
to include consent to subsequent disposal, storage or acceptable use of the tissue, provided 
that such use has been regulated by appropriate ethical, legal and professional standards. 
Genuine consent needs to be based on adequate understanding of the treatment, and 
explanations used in the consent procedures must make it clear that consent will include 
acceptable further uses of tissue removed during treatment. When comparing 
recommendation of the Nuffield Council and the existing literature from recent years, their 
most apparent difference concerns the form of consent. Most scientists would recommend a 
broader consent than proposed by the Nuffield Council. Again, latest report of Nuffield 
Council recommended that it is acceptable to ask participants to agree to their sample being 
used in any future research that is within the broad aims of the biobank and has been 
approved by a research ethics committee (Prainsack & Buyx 2011). 
It is also stated in Finnish law, the Medical Research Act (488/1999, 295/2004, 794/2010), 
that the research subject can withdraw his or her consent at any point prior to the 
completion of the research. This right must be informed before the start of the research. 
Withdrawal of consent and the resulting withdrawal from the research cannot cause any 
negative consequences for the research subject (Medical Research Act). In the international 
literature, there has been some discussion about whether withdrawal from research is 
acceptable in all situations (Chwang 2008, McConnell 2010). Chwang (2008) argued that in 
some cases, researchers must have a guarantee that subjects will not withdraw, and they 
must waive the right to withdraw from the study in order to produce beneficial results. 
However, McConnell (2010) came to the conclusion that any waiver of the right to 
withdraw would be unnecessary and if it were implemented, its overall impact would 
likely be negative. 
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2.2.6 Societal aspects  
In Finland, legislation on the biobank of government bill has been introduced to the 
Parliament in October 2011, and if Parliament agrees, the Act will enter into force in 2013 as 
the Biobank Act (Table 2). The role of the ethics committee is becoming central in the 
reviewing process (Watson et al. 2010) and informed consent process will be one of the key 
issues incorporated into the new Biobank law (Kääriäinen 2011). 
Biobank research has been widely discussed internationally (Eriksson & Helgesson 
2005b, Bell et al. 2009, Coebergh et al. 2006, Hansson et al. 2006, Nilstun & Hermeren 2006, 
Melas et al. 2010, Stjernschantz Forsberg et al. 2009, 2010, Watson et al. 2010). Tupasela and 
co-workers (2010) conducted a population survey (n=2400) into attitudes of Finns aged 24-
65 about the use of existing diagnostic and research samples, the setting up of a national 
biobank and different types of informed consent. The response rate of the study was 50%. 
Most of the respondents (83%) had little or no knowledge of what biobanks were and 77% 
regarded biobanks in a positive manners. About one in every three would not attach any 
conditions to their consent, almost half (41%) considered it important to regain consent 
when a new study contained several steps. There were respondents (30%) who wished to 
consent to be gathered for every new research project and would like to decide in which 
type of research their samples would be used (44%). One third of both men and women 
were willing to allow the use of their samples in research involving private enterprises. 
Furthermore potential participants wished to receive more knowledge about tissue 
donation (Tupasela et al. 2010).  
Internationally there has been some discussion about the ethics of using samples from 
deceased subjects in the context of longitudinal biobanking genetic research stressing the 
importance of using these samples in research (Tassé 2011). In Finland, in such situations 
the National Supervisory Authority for Welfare and Health, Valvira, can give permission to 
use these samples for research (The Act of the Medical Use of Human Organs and Tissues). 
New Biobank law will legislate on this matter (HE 86/2011).  
There seems to be consensus across professionals who work with human tissue, for a 
reform of the law towards a communitarian approach (Campbell et al. 2008) and to gather 
broad consent from participants (Stjernschantz Forsberg et al. 2009, Kääriäinen 2011). 
Consent is regarded as important, but tissues have been seen as a valuable resource for the 
entire community. One implication of this would be that the current emphasis on 
individual choice could be detrimental to the overall interests of society. (Tupasela 2008, 
Campbell et al. 2008). Clearly, one can envisage cases when there would be tension between 
individual rights and common good (Campbell et al. 2008).  
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2.3 APPLICATION OF ETHICAL PRINCIPLES IN TISSUE RESEARCH  
2.3.1 Types of tissues used for research and their implications 
The use of human biological materials and associated personal data are increasingly 
important for biomedical research (Vähäkangas 2008, CDBI 2011). The Nuffield Council on 
Bioethics (2011) has launched a general list of the types human tissue samples used in tissue 
research: 1) Organs and parts of organs 2) Cells and tissue 3) Sub-cellular structures and cell 
products 4) Blood 5) Gametes (sperm and ova) and 6) Embryos and fetal tissue. In clinical 
settings, human tissue for research purposes is removed from the body during the course of 
diagnosis or treatment, but may not be needed for these purposes anymore. Procedures 
that may furnish excess tissues can be surgical, diagnostic, clinical research, transplantation 
and/or autopsy: eg. amniotic fluid or pieces of chorion villus (part of the placenta) may be 
taken for cytogenetic or other diagnostic tests during pregnancy. Small pieces of tissue may 
be taken by biopsy for pathological examination and diagnosis, and larger amounts of 
tissue may be removed surgically during an operation for malignant or other diseases (Bell 
et. al. 2009, Allen et al. 2010, Nuffield Council on Bioethics 2011). In Finland, placenta is 
considered as waste and it is an example of a human tissue with a specialized function 
during the pregnancy in the body. However, once the placenta has completed its function 
and has been expelled from the body after birth, it is usually abandoned by mothers and is 
generally regarded as clinical waste. Occasionally, the placenta may be used to extract 
proteins of therapeutic value, such as albumin, which can be used for treating burns 
(Nuffield Council on Bioethics 2011). (Table 3.) 
The Steering Committee of Bioethics (CDBI 2011) categorized the materials that are taken 
from human beings for research use as falling into two broad categories: those that are 
destined for immediate use in a specific research project, and those that are to be stored for 
future use. According to the CDBI, this distinction is not absolute, in that part of a sample 
may be used straight away and the remainder retained for subsequent use. Furthermore, 
the CDBI states that the ethical issues for research involving human biological materials are 
two-fold: issues concerning initial removal of the material, which necessitates a physical 
intervention, and issues of consent/authorization and confidentiality concerning use and/or 
storage of the materials that have been removed.  
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Table 3. Source and use of human tissue for research and ethical aspects  
 
Source  Examples Ethical aspects  References 
Diagnostic or 
therapeutic procedures 
 
Blood or serum 
Scrapes of surface cells 
Many organs or tissues  
Invasiveness of the 
procedures 
Personal information, 
Storage, Genetic data, 
biobank 
Difference between care 
and research 
Informed consent  
Risks/benefits 
 
Vähäkangas 2004 
Kapp 2006 
Gillett 2007 
Hamilton et al. 2007 
Cambell et al. 2008 
Hewitt et al. 2008 
Al-Qadire et al. 2010 
 
Autopsy specimens Many organs and 
tissues 
Storage, Consent 
biobank 
Kapp 2006 
Gillett 2007 
Cambell et al. 2008 
Tassé 2011 
 
Tissue from healthy 
volunteers 
Small skin biopsies (for 
example fatty tissue)  
Blood 
Buccal cells 
Hair root sample 
 
Risks/benefits 
Informed consent, 
storage, genetic data, 
biobank 
Merlo et al. 2007 
Vähäkangas 2004 
Petrini  2010b 
Caplan & Moreno 2011 
Body waste Urine, faeces, sweat, 
hair, nail clippings 
Informed consent 
process 
 
Kapp 2006 
Waste tissue Placenta, cord blood Informed consent  
Genetic data 
Storage, Biobank  
Vawter et al. 2002 
Lind et al. 2007 
Petrini  2010a 
 
2.3.2 Ethics in human tissue research  
Regarding ethical aspects in tissue research, several topics have been addressed in the 
literature. The aim of the literature search was to determine what methods have been used 
related to the ethics in research with tissue specimens and have a general overview about 
this topic. The search was done with an information specialist in order to identify the most 
appropriate search terms. Search terms, databases and process of data selection are 
presented in appendix I. A total of 19 studies were selected as providing examples about 
studies in tissue research in clinical settings. The biobank research was excluded and thus 
some difficulties were encountered. The reason for this was that researchers appeared to 
collect samples for future use which may be called a biobank. If consent had been sought 
during care in the clinic and the purpose was to store samples for future use, then those 
articles were accepted into this survey (e.g. Mancini et al. 2011, Morrell et al. 2011).  
This literature consisted of qualitative (n=4), quantitative (n=7) studies and reviews of 
empirical studies (n=8) (Tables 4, 5, 6). The issues investigated and discussed in the 
literature commonly are informed consent (Faber et al. 1995, Furness & Nicholson 2004, Pentz 
et al. 2006, Campbell et al. 2008, Vermeulen et al. 2009 a,b, Treweek et al. 2009, Hens & 
Dierickx 2010, Mancini et al. 2011), attitudes towards tissue research (Farber et al. 1992,  
Cambell et al. 2008, Treweek et al. 2009, Hens & Dierickx 2010, Furnesss & Nicholson 2004, 
Morrell et al. 2011), willingness  to donate tissue (Furnesss & Nicholson 2004, Pentz et al. 2006, 
Morrell et al. 2011), IRB and consent (Merz et al. 1999). Discussion in the reviews of empirical 
studies have focused mostly on informed consent (Hoeyer & Lynöe 2006, Santa et al. 2008, 
Porteri & Borry 2008, Petrini 2010a, regulation and research governance in tissue research 
(Meslin & Quaid 2004, Hakimian & Korn 2004, van Veen 2008, Steinman 2009).  
 
 
 
 
20 
 
 
2.3.3 Qualitative tissue research  
Studies with qualitative methods (Table 4) mostly focused on informed consent of the study 
participants (Hens & Dierickx 2010, Mancini et al 2010, Morrell et al. 2011) but also views of 
professionals about ethical aspects in tissue research (Campbell et al. 2008). Hens & 
Dierickx (2010) interviewed adults and children, focusing on informed consent and 
different types of tissue donation, and on confidentiality. According to the results gained in 
the focus-interviews, it was found to be meaningful with respect to what kinds of tissue 
samples were being sought for research. The interviewed participants did not perceive a 
high risk associated with research on stored tissue, however they believed that 
confidentiality must be ensured. On the other hand, Mancini and co-workers (2011), used 
two different methods, interviews and questionnaire, in their study to determine opinions 
about informed consent in tissue research and use samples for future use. The opt-in 
consent (each person is informed about the research and their consent is sought) was the 
most popular option of the different forms of consent, but patients had difficulties in 
remembering or understanding what they had consented to. For example, patients did not 
know that they also consented to providing access to their personal clinical data later in the 
context of the biobank. Therefore Mancini and co-workers (2011) suggested that the 
informed consent process needed improving, which was in agreement with the conclusions 
of Hens and Dierickx (2010). Morrell and co-workers (2011) pointed out that even though 
the time available for decision was short; no sense of compulsion and manipulation was 
noticed.  
Tissue research in general was seen as beneficial and risk-free (Hens & Dierickx 2010, 
Morrell et al. 2011) except for the involvement of private companies and access to data 
(Morrell et al. 2011) unless they were in the area of medical practice (Hens & Dierickx 2010). 
However, no reward was expected by the participants (Morrell et al 2011) and research was 
seen as good for the community (Campbell et al. 2008, Morrell et al. 2011) and a more 
communitarian approach was suggested (Campbell et al. 2008). Some concerns about 
confidentiality were also brought up (Hens & Dierickx 2010, Mancini et al. 2011) and 
therefore anonoymous samples were considered as safe (Hens & Dierickx 2010). Opinions 
between adults and teenagers differed with respect to privacy protection. Teenagers 
showed great confidence towards scientists and were curious about research findings 
(Hens & Dierickx 2010).  
Campbell and co-workers (2008) stated that more education was required about ethical 
aspects in tissue research aimed at the professionals. In addition, it was stated that debate 
on ethical aspects in tissue research was needed. It was evident that the law itself was not 
sufficient and many ethical issues extended to areas beyond those covered by legislation. 
Three main areas of ethical concerns were identified by the writers: 1)the balancing of 
individual rights and social benefit to the community; 2)the efficacy of the new procedures 
for consent; 3) and the helpfulness for professional practice of the new legislation and 
regulation.  They concluded that recognition of these concerns could help in generating a 
new partnership between professionals and patients and their families (Campbell et al. 
2008).  
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Table 4.  Examples of methods used in qualitative studies concerning ethics in tissue research.  
 
Authors, year Method  Focus 
Campbell et al. 
2008 
Interview study 
 
Professionals (n=31) who had specific insights into 
different aspects of work with human tissue and organs. 
 
Hens & Dierickx 
2010 
Focus-group 
interview study 
Attitudes towards research on human stored tissue 
samples may be dependent on the cultural context. 10 
groups with 76 participants adults and children. 
 
Mancini et al 
2011 
In-depth 
interviews and 
questionnaire  
 
Opinions of cancer patients about consent process to 
donate tumor samples to research. Interviews n=19. 
Questionnaire n=745. Response rate 77%. 
Morrell et al. 
2011 
In-depth 
interview  
 
Attitudes of different stakeholders (n=12) towards tissue 
donation. Stakeholders were: patients (n=4), parents of 
children (n=2), health advocates (n=3), consumer 
representatives (n=2), indigenous representative (n=1). 
 
 
2.3.4 Quantitative tissue studies  
There were seven studies which were selected as examples of quantitative tissue studies 
(Table 5) Four of the studies focused on clinical care with left-over tissue (Vermeulen et al. 
2009a,b, Pentz et al 2006, Furness & Nicholson 2004). One study investigated public 
opinions about leftover blood sample for future use (Treweek et al. 2009).  The opinions of 
medical students (Farber et al.1992) and researchers (Merz et al. 1999) were also 
investigated.  
Attitudes towards donating tissues for research were positive (Pentz et al. 2006, Treweek 
et al. 2009, Vermeulen et al. 2009b) but not without consideration about the ethical aspects 
(Vermeulen et al. 2009 a,b, Treweek et al. 2009). Informed consent was one of the main 
points raised (Farber et al. 1992, Vermeulen et al. 2009 a,b Treweek et al. 2009). Even though 
people were willing to give consent to research and future use of samples (Furness & 
Nicholson 2004, Pentz et al. 2006), they were anxious to know about the possible use of 
their samples. Otherwise, most patients feel that if they have been adequately informed 
then there is no need to be asked for more than one-time general consent (individual is 
informed and actively asked for written permission for all future studies) for research with 
residual tissue. Nonetheless, some patients regard residual tissue as a part of them and few 
consider residual tissue to be waste (Vermeulen et al. 2009 a,b). In a comparison of different 
consent procedures, Vermeulen and co-workers (2009b) pointed out that the so- called opt-
out plus procedure (individuals are actively informed, verbally and by means of a leaflet, 
about the possibility to opt-out of all future research with their tissues) which they 
considered the best consent form, may unify two moral principles: patients are being 
informed but medical research can progress without unnecessary hindrance. Nonetheless, 
an open-ended consent was also considered as suitable for research with stored blood 
samples. Furthermore, linkage of samples to medical records was considered acceptable as 
long as the research had been approved by a research ethics committee (Treweek et al. 
2009). Furness & Nicholson (2004) stated that misuse of tissue samples can impact on the 
general public´s opinions in the United Kingdom (UK) and strict regulations have led to 
abandonment of international studies in UK.  
The literature also indicates that there is a need to educate researchers about the 
requirements involved when conducting tissue research such as the use of identifiable 
tissues as well as requirements for an Independent Review Board (IRB) review. Thus, some 
human tissue research was performed without IRB approval. Investigators who did not 
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obtain IRB approval did not understand the requirements (Merz et al. 1999). Faber and co-
workers (1992) suggested that researchers should spend more time discussing with patients 
in clinical settings and inform patients and obtain consent for the research. It was also 
noticed by the authors that the third and fourth year students were less adamant about the 
need to inform patients than first and second year students. Those who had experience 
with tissue research were more comfortable with requesting tissues from patients than 
those who had not participated in this work (Faber et al. 1992).  
Pentz et al (2006) found that it was essential to take care of cultural aspects and to ensure 
that the language used was understandable. However, no differences were found between 
two different ethnic groups in their opinions about the donation of biological samples for 
research.  Most of the patients, regardless of the site of care, ethnicity or socioeconomic 
status, were willing to provide a biological sample for research which would be conducted 
without contacting the patients again. However, the authors stated that time given for 
consideration about consent was important (Pentz et al. 2006).  
 
Table 5. Examples of methods used in quantitative studies concerning ethics in tissue research.  
 
Authors, year Methods Focus 
Vermeulen et al.  
2009a 
Questionnaire To determine which consent procedure patients would 
prefer for future research with tissue stored following 
surgery.  
Patients ( N=103), who had recently undergone surgery 
for breast or colorectal cancer 
 
Vermeulen et al.  
2009 b 
Questionnaire and telephone 
interviews, comparative study 
 
To determine what kind of consent procedure patients 
prefer and what are the effects of consent procedures 
on actual consenting behaviour. Options were:  One 
time consent procedure n=60 (response rate 93%), 
Opt-out plus n=77 (response rate 93%), Control group, 
standard procedure, opt-out n=131 (response rate 
88%) and telephone interviews (n=31, n=37, n=62). 
 
Treweek et al. 
2009 
Questionnaire, survey Attitudes of people recruited through general practices 
to donation and storage of blood left over from routine 
clinical tests in general practice (N=2471), response 
rate 34%. 
 
Pentz et al. 2006 Questionnaire,  
comparative study 
 
To compare the views of two groups of patients who 
were given the option of tissue banking. African 
American and white American cancer patients (N= 453), 
response rate 70%. 
 
Furness & 
Nicholson 2004 
Questionnaire To obtain general consent for research use of surplus 
tissues from renal transplant biopsies in the renal 
transplant unit in Leicester.  
 
Merz et al. 1999 Review of Journals and 
telephone survey with 
questionnaire  
 
To examine the degree to which published studies 
involving human tissue document IRB approval and 
informed consent. Original articles, research reports and 
technical correspondence of 9 journals (n=105 papers). 
Authors (n=85) in telephone survey with questionnaire.   
 
Farber et al. 
1992 
Questionnaire  
 
Attitudes of medical students (N=4057), towards 
informed consent and the patient-physician relationship 
in regard to the research use of tissue. Response rate 
33.7%. 
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2.3.5 Theoretical aspects of tissue research 
In the published literature, theoretical considerations about human tissue research with 
ethical aspects have been widely discussed (Table 6) Most of the reviews or considerations 
have involved the informed consent process (Hoeyer & Lynöe 2006, Santa et al. 2008, 
Porteri & Borry 2008, Steinman 2009, Petrini 2010a). There is almost a consensus about the 
necessity of respecting the donors’ personal choice (Santa et al. 2008, Steinman 2009, Petrini 
2010), but problems arise from the ownership of the samples (Petrini 2010a) and the extent 
of information to be given to the participants (Porteri & Borry 2008, Meslin & Quaid 2004). 
However, as also supported by the literature, consent needs to be given without pressure 
(Hoeyer & Lynöe 2006, Porteri & Borry 2008, Steinman 2009, Petrini 2010a) and it should be 
clear who owns the samples (Petrini 2010a). In addition, the importance of tissue research is 
recognized (Meslin & Quaid 2004, Hakimian & Korn 2004, Santa et al. 2007, Steinmann 
2009).  
The informed consent process in the context of umbilical cord blood may be problematic 
for several reasons. For example, ownership of the sample has ethical and legal aspects. The 
question has been asked about whether the mother has the right to give consent or should 
the father also be involved. The general opinion is that the mother has right to sign the 
consent although involvement of the father may be recommendable (Petrini 2010a). 
In the context of tissue banking, Steinmann (2009) has presented the opinion that the 
focus of autonomy should shift from individual capacity to autonomy as part of 
institutional practices and rules. The reason is that if the benefits of research are considered 
to lead to a common good and to satisfy interests of the general public, research has to be 
controlled through public intervention. Therefore, autonomy cannot be controlled by 
referring only to personal interest and individual self-determination (Steinmann 2009). 
Alternatively, Porteri & Porry (2008) stated that aspects of the donor need to be considered, 
she/he should be provided with individual sufficient information about the present and 
future use of samples. Also consideration of the specific biological and genetic aims of the 
research should be performed. 
 Santa and co-workers (2007) stated that ethical aspects in tissue research are important 
but for instance in retrospective studies with human tissue, it may be possible to guarantee 
donors rights by presumed consent. In addition, they considered that the benefits would 
likely outweigh any risk of damage to personal privacy or the very limited damage to 
property rights of an individual as long as personal choice had been respected. Likewise 
Hakimian & Korn (2004) stressed the importance of tissue research and its beneficence to 
the society which according to them can justify the fact that society can make exhaustive 
use of samples based on principle of justice.  
Research governance of the tissue samples is seen requiring a fair balance between 
different stakeholders in research. Patients should be considered as biosocial citizens who 
are co-workers with researchers against the paternalistic attitudes of some ethicists and 
regulators (van Veen 2008). The basic principles of governance have been argued as 
requiring transparency (van Veen 2008) but not creating extra bureaucracy (van Veen 2008, 
Petrini 2010a) as well as protecting individual rights (Steinmann 2009). That is, research 
governance framework should not establish rules but principles which provide enough 
flexibility for the specifics of a project (van Veen 2008). In addition, education of the public 
and other stakeholders is needed (Meslin & Quaid 2004) not forgetting the responsibilities 
of the institutions (Hoeyer & Lynöe 2006, Steinman 2009). According to Meslin and Quaid 
(2004) regulatory reform will take some time, institutions and their ethics committees 
should begin to act to familiarize themselves with the projects involving HBMs (human 
biological materials) and begin to develop educational and policy strategies for anticipating 
difficulties in informed consent, assessment of risks and benefit and related human subject 
issues. Efforts should be made both to inform the public of the need for HBMs and to 
develop the policies and protections that would foster trust in such an endeavour. 
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Hoeyer & Lynöe (2006) concluded that ethical scrutiny should redirected away from 
informed consent towards issues concerning institutional arrangements and social 
responsibility.     
 
Table 6.  Examples about theoretical articles concerning ethics in tissue research.  
 
Authors, year Focus Main results 
Petrini C 
 2010a 
Ethical issues of umbilical cord 
blood collection, storage and 
use. 
Concept of informed consent is problematic because of the 
ownership of the cord blood. Content of the consent needs to 
be clarified as well as form of consent. Father’s involvement is 
recommended for the consent process. 
Steinman  
2009 
Concerns of the uncertainty in 
current proposition for the 
regulation of tissue donation. 
If the benefits of research are considered to lead to a common 
good and to satisfy public interests, then research has to be 
controlled through public institutions. Autonomy does not 
exclude institutional support, as institutional support is the only 
way to take the autonomy of donors seriously. 
Porteri & Borry 
2008 
Model of informed consent for 
the collection and storage of 
biological materials for research 
purposes. 
Informed consent for the use of biological materials shall give 
donors sufficient information to make informed decisions about 
possible present and future use of the sample. Also 
consideration of the specific biological and genetic aims of the 
research should be performed. 
van Veen  
2008 
Discussion about obstacles to 
European research projects with 
data and tissue. 
Good research governance is a fair balance between the 
interests of all stakeholders. It should make the basic principles 
transparent on which observational research projects are based 
in line with European solidarity-based healthcare systems. 
Research governance framework should not establish rules but 
principles which provide enough flexibility for the specificity of 
a project. 
Santa et al  
2007 
Use of human tissue in medical 
research and ethical 
considerations on it. 
The benefits deriving from the use of human tissue are likely to 
be greater than any improbable risk of damage to personal 
privacy or very limited damage to property rights of the 
individual, as long if personal choice has been respected.  
Hoeyer & Lynöe 
2006 
To explore the contribution from 
social anthropology to the 
medical ethical debates about 
the use of informed consent in 
research with human tissue. 
There is reason to redirect the ethical scrutiny from informed 
consent to issues concerning intuitional arrangements and 
social responsibility. The authors suggest that an anthropologic 
approach could facilitate a reconsideration of the political 
implications of using informed consent as a regulatory practice 
in tissue-based research. 
Hakimian & Korn 
2004 
Discussion about the legal, 
regulatory and ethical 
framework within human tissue 
research. 
Human tissue specimens are unique and irreplaceable research 
source. Society’s strong interest in the advancement of medical 
knowledge deserves a coherent and internally consistent legal, 
regulatory and ethical framework to govern specimen use.  
Society may justify the expansive use of these samples based 
on the principle of justice. 
Meslin & Quaid 
2004 
Discussion about storage, use 
and regulation of human 
biological material (HBM) 
research, misuse of genetic 
information, economic factors as 
well as public knowledge.  
Institutions and their IRBs should begin to act to familiarize 
themselves with the projects involving HBMs and begin to 
develop educational and policy strategies for anticipating 
difficulties in informed consent, assessment of risks and benefit 
and related human subject issues. Efforts should be made both 
to inform the public of the need for HBMs and to develop the 
policies and protections that would enhance trust. 
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2.3.6 Ethics in human placental research 
The use of human placenta has increased in biomedical research in the past few years 
(Schneider et al 1972, Pienimäki et al. 1995, Vähäkangas & Myllynen 2006, Annola et al. 
2009, Karttunen et al. 2010, Partanen et al. 2010). In an attempt to identify the published 
literature about ethics in human placental research, a systematic search was conducted in 
the PubMed, Ebsco and Scopus databases. The first search was done using terms placenta*  
ethics*, and 4 suitable articles could be retrieved (Appendix II) selected. Then a manual 
search was conducted in four journals: Bioethics, Journal of Medical Ethics, American 
Journal of Bioethics and Nursing but no relevant articles were found in this way. Two of 
the studies selected from the first search were about cord blood, which was not a keyword 
in this search. The reason for their inclusion was the consideration of recruitment process 
which can be used in placenta research generally as presented by Vawter et al (2006), and a 
discussion about ethical principles, informed consent and commercialization of research, as 
presented by Salvaterra et al (2006). Two of the selected articles were theoretical (Salvaterra 
et al. 2006, Vawter et al. 2006), one was a review (Jenkins & Sugarman 2005) and one article 
was based on qualitative interviews (Lind et al. 2007).  
The ethical aspects of human placental perfusion were investigated in the study of Lind 
et al (2007). They interviewed 19 mothers and fathers in Denmark. The results showed that 
generally mothers were willing to donate the placenta for perfusion studies. They felt that 
face to face interaction, written information material and an informed consent form all 
played an important role in creating trust in this type of research. The mothers viewed the 
placental perfusion study as a gift to the health care system from the donor, and the 
importance of the medical research was the general opinion expressed. The interviews were 
performed one day before caesarean section (Lind et al. 2007).   
The placenta and cord blood are known to be an important resource for stem cell 
research (Salvaterra et al. 2006). In a theoretical article Vawter and co-workers (2002) paid 
attention to the recruitment process in cord blood collection for research purposes. They 
argued that consent process could differ on whether consent was required or obtained 
before labour, during labour, or after collection for blood collected in utero or ex utero. One 
important factor was the participation of midwives or doctors in the decision-making 
capacity and if the mother was capable or interested, then brief information could be given. 
Consent should be asked after delivery. This is accordance with the work of Lind and co-
workers (2007); their results indicated that some written information material should be 
provided to the participants in advance. However, some mothers mentioned that the mere 
opportunity for asking questions and making suggestions increased the degree of openness 
and created an atmosphere of trust. 
Jenkins & Sugarman (2005) have highlighted the fact that incorporation of sensitivity to 
the cultural meanings and delineation of these meanings should be taken into account in all 
research involving human material. For instance, the placenta may have different 
significance in different nations e.g. companion to child, protection and healing, link of the 
child to the community and social identity of child, whereas in the Western world, the 
placenta is usually regarded as waste. The need of tissue for research materials has raised 
ethical questions e.g. how best to ensure continuing public support for the banking of 
human biological material and the protection of individuals and communities from harm as 
a consequence of participation in research (e.g. see Jenkins & Sugarman 2005).  
On the other hand, Salvaterra et al (2006) pondered questions about ownership, 
informed consent and commercialization of cord blood banking, which they felt should also 
be taken into account. In their opinion, when cord blood was simply considered as a waste 
product of childbirth, its use did not raise ethical and legal questions with regard to 
ownership. However, at present, cord blood and the placenta itself have been identified as 
a valuable resource, and it has become crucial to identify owner rights for these materials. 
Moreover, it is surprising, that there are so few studies concerning ethics in placental 
research in view of the fact that placenta has been used for decades as a valuable research 
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material for instance in studies investigating diseases of fetus with placental involvement 
(Guller et al. 2011), gene expression (Avila et al. 2010 ) and as a source of human proteins 
(Shin et al. 2010 ). It has been speculated that as the need for human models and tissue in 
research increases (Pasanen et al. 1990, Prouillac et al. 2010), important and new ethical 
aspects in research using tissue will emerge. From the ethical point of view, the opinions of 
different stakeholders will help in improving the practice of recruitment.   
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3 Aims of the study 
Ethics is a fundamental aspect of scientific research. Most of the studies on ethics have 
focussed on informed consent from the point of view of the participants. There are few 
studies on the views of different stakeholders in research using human tissues. However, 
such data, if available, may contribute to improving the ethical conduct of recruitment and 
may increase participation in this kind of research.   
This study is a part of a larger research programme on environmental carcinogenesis and 
fetal exposure to carcinogens. The placental perfusion method can be utilized to 
characterize fetal exposure to chemical compounds. The ultimate aim of this present study 
was to examine ethical aspects in tissue research. It is important to know how the 
stakeholders in research utilizing human tissues perceive their participation and how the 
protection of their rights is guaranteed by the ethical framework.  
 
 
The specific objectives were as follows: 
 
 
1. To evaluate the views of stakeholders i.e. placenta donors, recruiters and 
researchers, about the recruitment and informed consent processes in human 
placental perfusion studies. 
 
2. To describe the views of stakeholders about the risks and benefits and confidentiality 
in human placental perfusion studies. 
 
3. To assess the views of stakeholders in human placental perfusion studies about the 
societal meaning of scientific research. 
 
4. To analyze how scientists consider the ethical aspects of their research. 
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4 Methods 
4.1 PARTICIPANTS AND DATA COLLECTION  
4.1.1 Participants in studies 1-3 
Data were collected using multiple methods to interpret the stakeholders’ views about the 
ethical aspects in tissue research. The purpose was to obtain an accurate representation of 
reality. Data triangulation was used to produce new and diverse information in the studied 
topic (Polit & Beck 2006).  
Participants in studies 1-3 (original publications 1-3) were stakeholders in human 
placental perfusion studies: 1) mothers who donated their placenta 2) midwives who 
recruited the mothers and 3) human placental perfusion studies researchers. (Table 7.) 
Study 1 participants were mothers (n=25) who gave birth at the University Hospital of 
Kuopio. They donated their placenta for the placental perfusion study and were asked one 
day after delivery for consent to be interviewed at a later stage. Participants met the 
following criteria: 1) able to give informed consent, 2) Finnish speaking and 3) living in the 
area of the Hospital District of Northern Savo. Recruitment for the first 4 interviews was 
carried out by the nursing staff at the ward. Four mothers were willing to participate in the 
interview and six refused. The first four participants recruited for the study suggested to 
the interviewer that she herself should be the one to carry out the recruitment for the 
interviews. Therefore, after the first four cases, the recruitment strategy was changed as 
proposed. The researcher became in charge of the recruitment herself and met 26 new 
mothers, of which 21 were willing to participate while only five mothers refused (thus the 
total number of interviewed mothers was 25). Mothers were given information about the 
interview both verbally and in a written form. If the mother was interested in participating, 
she gave her telephone number and she was contacted one week after discharge.  Mothers 
were asked to discuss the study with their families and they were told about the possibility 
to withdraw their consent by using a text message at any time without any further 
consequences. If the mother was willing to meet one week after being contacted, the day 
was set for the interview and the mother chose the place for the interview. One interview 
took place in the hospital at the maternity ward because the child was ill and was still being 
treated in the NICU. One interview was carried out in the university and the other 23 at the 
mothers’ home. For details of the recruitment process, see original publication 1. 
Study 2 participants were midwives (n=20) who worked in the university hospitals of 
Kuopio and Oulu and had experience in recruiting mothers for placental perfusion studies. 
The contact persons in the hospitals were the head nurses of a total of five wards. The 
research project was introduced during a ward meeting, and the wards were provided with 
fact-sheets about the research along with the researcher's contact details. Seven midwives 
from Kuopio and thirteen midwives from Oulu volunteered to be interviewed. More 
information is presented in original publication 2.  
Study 3 participants (n=23) were international researchers with experience in human 
placental perfusion studies. Data were collected from focus group interviews and an open-
ended questionnaire in English. Two of the researchers´ focus interviews were conducted 
during an international seminar held in Kuopio, and one was arranged after the seminar.  
Before the seminar, an e-mail was sent to the participants informing them of the possible 
interview. Verbal information was also given before the interview. Focus-group interviews 
were arranged in a private room. The questionnaire was sent by e-mail to researchers and 
research groups known to carry out human placental perfusions. Since the first round of e-
mails produced only 6 responses, a second e-mail was sent to those who did not respond. 
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At the end, out of 18 research groups, responses were received from 5 different groups, 
with a total of 14 responses. The questionnaire was also sent to 11 individual researchers, 5 
of whom responded. Thus, the total number or returned questionnaires was 19. Eight of the 
questionnaire respondents also participated in the focus group interviews. 
4.1.2 Documentary material in study 4  
Study 4 data were collected from applications received by the regional ethics committee 
in the Hospital District of Northern Savo. The ethical statement was copied from either the 
application form (years 2004-2005) or from separate statements. A manual search was 
performed of all the applications sent to the ethics committee during the years 2004-2009 
(n=688). The exclusion criteria were: 1) only a blood sample was taken, 2) tissue was taken 
from a deceased person. After these exclusions, 56 cases remained (Table 7) 
 
Table 7. Data collection in studies 1-4  
Study Study 
population 
N Method Time of 
the study 
Amount 
of data 
Study 1 Mothers 
 
25 Thematic interview 2007–2008 324 pages 
Study 2  Midwives  20 Thematic interview 
 
2008–2009 351 pages 
Study 3 Researchers  
Part 1 
 
Researchers 
Part 2 
12 
 
 
19 
 3 Focus-group interviews  
 
 
Open-ended 
questionnaire 
 
2009-2010 
 
 
2009-2010 
43 pages 
 
 
81 pages 
Study 4 Statements of  
principal 
investigators  
56 Analysis of documents 2004-2009 1) 
1) Amount of data was from few lines to 2 pages ethical statement prepared by the principal investigator 
4.1.3 Interviews and themes  
The structure and themes of mothers’ and midwives’ interviews were compiled according 
to a questionnaire developed in the context of the NewGeneris project, by the group that 
studied the socio-ethical impact of environmental health research at the Centre for Human 
Genetics of the Catholic University of Leuven (Belgium) and a related publication 
(Beauchamp & Childress 2001). Field notes of all interviews were written down during or 
immediately after the interviews. During the interviews in studies 1-2, more information 
about the perfusion research was given to the mothers and midwives, in order to help them 
to express opinions about the benefits/risks and societal meaning of research in general as 
well as placental perfusion research in particular. The interviews lasted for 60 minutes on 
average.  
The focus-group interviews and questionnaire of the researchers were also structured 
according to the same themes that were used in studies 1-2 (Table 8).  Participants in the 
focus-group interviews (n=12) represented 7 different nationalities. The interviews lasted 
about 60 minutes and were interactive. The saturation point was achieved during the third 
focus group interview, after which no new focus groups were planned.   
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Table 8. Themes used in studies 1-4. 
Theme Content  
 Recruitment  
 
 Recruitment situation 
 Participation in the research 
 Decision making 
 
 Informed consent and voluntariness 
 
 Comprehension of written and oral information 
 Voluntariness  
 Realisation of voluntariness  
 Communication 
 
 Risks and benefits of the research  
for participants 
 
 Meaning, significance and stressfulness  
 Handling and confidentiality  
of personal data 
 Concerns for preserving privacy 
 
 
 
 Societal meaning 
 
 Meaning of the tissue research in general  
 Meaning of science in general 
 Connection between political decision making 
and science 
 Justification for the research 
 
4.2 DATA ANALYSIS 
The interview data were written down word-by-word into a database. The transcriptions 
were compared with the original recorded data to ensure accuracy. The data were analyzed 
using thematic content analysis, and the answers were grouped and the concepts with 
similar content were combined to form upper concepts (Graneheim & Lundman 2004, 
Malterud 2001, Elo & Kyngäs 2007). Simplified expressions were sought from the data (an 
example from the study 4: “Purpose of the research is prevention...”), out of which upper 
concepts were created (in this case” health promotion”). Data of the mothers were analyzed 
manually.  Interview data of the midwives were analysed using the NVivo 8 software, 
which has been shown to be applicable for research with large quantities of data (Feely et 
al. 2007, Gottfredsdottir et al. 2009, Everett et al. 2011). NVivo 8 is a software package 
produced by QRS International and it is designed for qualitative researchers who need 
deep levels of analysis for small or large volumes of data. Coding data in NVivo 8 involves 
the creation of nodes. A node is a collection of references about a studied theme; in this 
study, the nodes were interview themes. In NVivo, the researcher can create different types 
of nodes during the coding process by reading through references and then categorising 
this information. Tree nodes were used when data were being organized in a hierarchical 
structure (Bergin 2011).  
In study 3, the interview data and questionnaire data were analysed using the NVivo 8 
software. Both data were analysed thematically (Graneheim & Lundman 2004) according to 
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interview themes and with data triangulation (Foss et al. 2002, Polit & Beck 2006, Lambert 
et al. 2007). Descriptive words and phrases were transferred into the NVivo system. This 
process was repeated until no new concepts emerged. The results section presents the 
opinions that have been selected as providing a diversified description of the discussed 
topic. The aim was to select a balanced sampling of opinions from all informants.  
In study 4, the data were collected manually. The study protocols in years 2006-2009 
were read against the exclusion criteria, and if the criteria were not met, the statement was 
copied.  In years 2004-2005, an ethical statement was included into the application form. A 
separate statement was also allowed. The content of the statements was analyzed for the 
same five themes as in studies 1-3: recruitment, informed consent, risk and benefits, 
confidentiality and societal meaning of the research. The statements were read and 
meaningful concepts and information were grouped under the selected themes, after which 
thematic content analysis was carried out (Prior 2010). If a theme was addressed in even 
one sentence, this sentence was included as a statement within that theme. The data were 
analysed both qualitatively and quantitatively. 
4.3 ETHICAL CONSIDERATIONS 
There is little research conducted on the ethics of studies involving pregnant women. Most 
studies have targeted clinical trials in pregnant women where the potential physical harm 
for both the mother and baby has been the main objective (McCullough et al. 2005, 
Helmreich et al. 2007, Wild 2007). The paucity of the studies about ethical aspects in 
placenta and tissue research in this form can be regarded as a justification for the study. Of 
the various ethical aspects of the scientific process (Vähäkangas 2004, Merlo et al. 2007), 
especially recruitment, data collection and the choice of research methods were noted in 
this research design. The interviews of the mothers were the most sensitive of all these 
interviews: breastfeeding mothers have been mentioned as a vulnerable group in the 
Medical Research Act (488/1999, 295/2004, 794/2010) although this kind of study did not 
interfere with the mothers᾽ physical integrity. However, the sensitivity of the situation must 
be considered carefully.  The purpose of the interview of the mothers was to collate the 
views of the mothers who had donated their placenta for the placenta perfusion studies. It 
is evident that this type of research can only be performed with this vulnerable group.  
It is self-evident that having a baby is a sensitive situation for a mother, and thus the 
recruitment process was planned carefully allowing time before coming to a decision. The 
mothers were visited at the hospital one day after their delivery. Before entering the room, 
nurses asked if it suited the mother to be asked to participate in the research. After 
receiving some brief information and a short conversation, a written information sheet was 
given to the mothers. They had 1-2 weeks time to consider their possible participation. 
Telephone number/e-mail address was given to the mothers so that they could cancel, if 
they so wished, their participation by sending a text message or e-mail.  
The literature (e.g. Beauchamp & Childress 2001) and legislation (Medical Research Act 
488/1999, 295/2004, 794/2010) as well as international guidelines (WMA 2011) emphasize 
that participants should have autonomy in deciding whether or not to participate in a 
research projects. This means that relevant information must be given to the participants 
and their competence to make the decision should be evaluated (Beauhamp & Childress 
2001, Medical Research Act). The purpose and methods of the research were explained in 
the information letters and understanding was ensured verbally in all interviews in studies 
1-3. The participants were asked to sign a consent form before the interview and they were 
told that they could withdraw their consent at any time according to the legislation and 
international agreements (Medical Research Act, WMA 2011).  
The interviews of the midwives were done mostly during their work time; four of them 
were done elsewhere. In the recruitment process, the contact persons were approached by 
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email, and they in turn asked possible volunteers to attend the interview. All interviews 
were conducted in a quiet place to ensure confidentiality. The midwives were also told that 
answering the questions was voluntary. An uncomfortable situation and possible guilt 
about one’s lack of knowledge can been viewed as a risk here. After the interview, the 
midwives had the chance to ask questions about the interview and talk about their own 
feelings at the time.  
Participants in the researchers´ focus-interviews were recruited in a seminar and by e-
mail. Before the seminar, an e-mail was sent to the participants informing them of the 
possible interview. Verbal information was also given during the seminar. At the beginning 
of the focus-group interviews, the participants were told that the interview would be 
confidential. Confidentiality was respected and only code numbers were used after the 
interviews to refer to the respondents. The questionnaire included a research information 
letter which emphasized that participation was voluntary. The questionnaire was sent 
twice, which is a normal procedure (Caminiti et al. 2011). All data was stored in a locked 
place, first at the University of Kuopio (currently University of Eastern Finland) and later at 
the Research Unit of the Hospital District of Northern Savo. 
Documentary material was collected by two researchers. Statements or application forms 
were copied and stored in a locked place in the Research Unit of the University Hospital of 
Kuopio. The content of the documents was read and analysed by member in the research 
group, and the names of the principal investigators were not mentioned in the discussions 
between research group members. Confidentiality was also respected in the analysis 
process to avoid identification of the research group.   
The official Research Ethics committee of the Hospital District of Northern Savo has 
provided a favourable opinion for interviewing the mothers (21.08.2007, 79//2007). Prior to 
the interviews of the midwives and the data collection in study 4, administrative approval 
was asked and received from the participating hospitals. 
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5 RESULTS 
5.1 VIEWS OF THE STAKEHOLDERS ABOUT RECRUITMENT AND 
INFORMED CONSENT 
In the placental perfusion studies, recruitment took place at the hospital and was 
performed by midwives and researchers.  All stakeholders in placental perfusion studies 
were content with the hospital recruitment and regarded it as acceptable. However, there 
was also frequent discussion in the interviews about the possibility of recruitment before 
entering the hospital and about providing some information prior to recruitment, e.g. in the 
maternity clinic.    
The fact that mothers were recruited into the placental perfusion studies in the ward 
before an elective caesarean section and in the delivery room before a normal delivery was 
seen as problematic by all parties. Haste in the ward and the fact that recruitment occurred 
during a care procedure was regarded as negative, and midwives pointed out that they 
tried their best to find time for recruitment.  Mothers noted that having enough time to 
familiarise themselves with the research and obtaining adequate information about the 
operation and the research from a familiar nurse were factors that enhanced positive 
feelings at the recruitment time. The researchers also thought that the recruiter should be 
someone who knew the situation in the ward and had sufficient information about the 
research. There were other aspects that also affected the recruitment situation for the 
mothers, for instance, allowing sufficient time to be spent with nurses. Generally, the lack 
of concerns in life increased contentment and peacefulness. Regardless of the fear and 
nervousness of the approaching labour, all the mothers were satisfied about their 
participation in the placental perfusion research and regarded it as important.  
Mothers who were recruited in the delivery room and the midwives doing the recruiting 
described the recruitment situation especially in the delivery room, but also sometimes in 
the ward, as challenging. Both groups thought that the mother was experiencing intense 
emotions such as fear and pain. This was due the delivery itself, the hurry in the ward as 
well as worries about the baby. The recruitment situation was thus considered as being far 
from restful.  The mother’s nervousness was described regardless of the mode of delivery. 
This sentiment was created by the novelty of the situation, the inability to concentrate, and 
the lack of information about both the operation and the research. All stakeholders in 
placental perfusion studies described hurry, e.g. for mothers this was interpreted as nurses 
waiting for the signature by the bed and an inconvenient situation overall. The midwives 
agreed with this although they had tried their best to provide time for the mother to make a 
decision.   
Mothers considered their participation in the perfusion studies as being voluntary, 
which was also confirmed by the midwives. According to the mothers, the main reason for 
this perception was the way midwives explained the research to them and made clear that 
their participation was completely voluntary. There were other factors that promoted 
voluntariness: sufficient time to read the information leaflet, privacy and lack of any 
financial benefits for the participants. From the mothers’ point of view, voluntariness meant 
that the decision was not influenced by persuasion but it was the participant's own decision 
and they felt right about it. It was also important to them that the decision would not affect 
their care in the hospital. Providing information in a way that was intelligible to the 
participants was also important: understandable language was considered as a part of 
voluntariness.  
Donating the placenta was something that the mothers decided on their own, without 
discussing it at recruitment time with their spouse or the midwife. In general, according to 
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the midwives and mothers, there was not a lot of discussion about the study. Both 
midwives and mothers pointed out that mothers gave their consent almost immediately. 
Midwives had the impression that the mothers did not thoroughly consider the 
implications. Most mothers did not ask any questions, and those who did, asked only some 
basic questions like where the placenta went and how it would be used. Those researchers 
who were recruiters regarded the information more accurate if it came from the researcher 
who knew all the details of the study. Mothers preferred midwives rather than scientists as 
the recruiters in the placental perfusion study, and midwives were also confident about 
being the recruiters.   The researchers emphasized that they did not recruit in the delivery 
room.  Some mothers regarded the option also to contact the perfusion researchers as 
important. Some mothers thought that nurses were insufficiently aware of the relevant 
information of the perfusion study and that the knowledge of the nurses was inadequate to 
provide them with the relevant information. Midwives agreed that they did not have 
knowledge about the perfusion studies or research methods in general. The researchers 
proposed that organisations/research groups should employ trained research 
nurses/midwives who were familiar with and trained in the used of research methods.  
The mothers were of the opinion that there was usually no in-depth conversation 
between the mothers and the midwives. The mothers felt that the communication was 
mostly equal, although they had expected more dialogue. The nature of the discussion and 
the language that was used influenced their willingness to participate in the research. The 
information provided in the written form was adequate according to the mothers, but they 
also wished to receive more verbal information from the midwives. Researchers paid 
attention to the hurry which disturbed communication with nurses. They also wondered 
whether the nurses’ attitudes towards research in the delivery room affected the way they 
acted in the recruitment situation. Mostly researchers considered communication with 
hospital personnel as being positive, but this was also something that could be improved in 
the future. Also, regular meetings and training sessions were seen as being useful.  
“Midwives’ contribution is absolutely crucial, so I think they should be regarded as partners, rather 
than “a source” of patients.” All stakeholders were confident that good communication 
created trust and increased the amount of participation in the research.  
In general in tissue research, researchers do not pay attention to the recruitment situation 
in their ethical statements. After the ethics committee revised their instructions in the year 
2006, some more information was added to the statement. Most of the recruitments (about 
80%) were done in the hospital during care. Although the recruitment situation was 
explained in the statements more often after the year 2006, the ethical statements did not 
include all the detailed information e.g. on how to inform recruiters or whether the 
recruitment situation was sensitive and the patient was competent. Only if persons without 
the capacity to consent were involved, was there discussion about their competence to 
participate and their relatives were asked to became part of the consent process. 
Furthermore, the most common description of informed consent process only mentioned 
the request of a written informed consent and the possibility to refuse participation. 
Voluntariness, the possibility to discontinue the research and the time to be given for 
invited participants to make their decision were not defined in most of the statements.  
Examples of expressions by the stakeholders in tissue research concerning elements of 
informed consent are presented in table 9. 
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Table 9. Examples of expressions by the stakeholders in tissue research concerning elements of 
informed consent 
Elements of 
informed consent  
Mothers Midwives Researchers Principal 
investigator 
Competence to 
understand and 
decide 
”At the same time 
with the care 
procedures, I was 
a bit anxious.” 
“I do not prefer 
delivery ward as 
the best place to 
recruit mothers.” 
“We never see the 
mother, we always 
go through these 
nurses or 
midwives. They ask 
them. Well, it’s 
easier for us, but 
I’m not sure how 
well nurses can 
explain the 
experiment to the 
mothers.” 
 
Only if persons 
without the 
capacity to 
consent (e.g. 
dementia) were 
involved, 
otherwise not 
discussed. 1) 
 
 
Voluntariness in 
deciding 
“I have time, no 
one is standing 
beside my bed 
waiting.” 
“Mothers have 
different kinds of 
thoughts in their 
minds, baby, and 
delivery.  It 
reflects on 
everything." 
"Freedom. Respect. 
Because if they are 
not willing to 
donate you cannot 
force them, you 
cannot keep asking 
her why you don’t 
want to donate 
your placenta to us 
and all." 
 
"It is voluntary 
and they can 
withdraw 
anytime." 
Disclosure of 
material 
information 
”I have got the 
relevant 
information and I 
had to understand 
it, and it is my 
responsibility to 
ask.” 
“If mothers do 
not have enough 
time, they cannot 
understand what 
they are doing.” 
“I implemented a 
new strategy that 
involved putting a 
patient information 
sheet in every 
section information 
pack that got 
handed out to 
women that were 
having a C-section. 
 
"Material will be 
given before 
delivery in 
writing and 
orally." 
Recommendation 
of a plan 
“I have to know 
what I sign up 
for.” 
"We should have 
more information 
about how to 
inform mothers 
and what 
informed consent 
is." 
“I think that 
sometimes the oral 
information is in a 
minor role; if the 
mothers don’t ask 
then midwives 
might not tell them 
as well about 
research.” 
 
Not mentioned in 
the documents 1) 
Understanding of 
disclosure and 
recommendation 
"I understood as 
much as lay 
people can in this 
kind of research." 
“I hope they 
understand, but I 
am not sure.” 
"I think that the 
way HOW you ask 
and WHEN you ask 
the permission is 
very important. 
The one who is 
asking the 
permission should 
be trustworthy and 
encouraging, but 
let the mother 
make her own 
decision." 
 
"Consent will be 
asked also from 
a relative if there 
is doubt that the 
patient does not 
understand." 
  
36 
 
 
Table 9. Continued. 
Decision in favour 
of a plan 
“I did not discuss 
it with my 
husband, he heard 
that I will donate 
the placenta, we 
did not talk about 
it.” 
”I hope decision 
is truly informed, 
there should be 
enough time. It 
depends on nurse 
also.” 
“I think it’s the 
mother’s 
responsibility to get 
agreement with her 
husband or her 
family members 
because in my 
culture families are 
whole, so we 
should contribute 
in every important 
decision. Or every 
family member 
should contribute 
to make the 
decision. So to me 
if we can get the 
consent of the 
mother that means 
we get the consent 
from her family. “ 
Not mentioned in 
the documents 1) 
Authorization of 
the chosen plan 
“ I gave my 
placenta to the 
research, I signed 
the paper, 
commitment and 
fair play (mother 
and researcher).” 
“I tell to the 
mothers about 
the research and 
signature is 
included the 
protocol. I leave 
the papers, 
mother can sign 
later.” 
 "So it is not the 
mother just 
signing, “Yes, take 
the placenta” but 
no, we need 
information from 
her to be included 
in the studies or 
research." 
"They will be 
asked to sign the 
consent." 
1) Not discussed in the analyzed statements  
5.2 VIEWS OF THE STAKEHOLDERS ABOUT RISKS, BENEFITS AND 
CONFIDENTIALITY 
The most important point raised by the mothers under the risks and benefits theme was the 
reliability of the research personnel in placental perfusion studies.  All mothers had read 
the information leaflet and they pointed out that having the University and professors 
involved in the research conferred reliability to the situation and made participation easier. 
Placenta research, as well as other tissue research by the principal investigator, was not 
seen as a risk for the participants. Mostly, the samples were considered as waste and 
therefore no risk was seen. “This is important research; I do not get any specific benefit for myself 
(Mother).” 
According to the interviewed mothers, they did not know the details of the placental 
perfusion studies. The midwives were also concerned about their own knowledge of the 
research, methods and scientific research in general. The lack of respect from scientists was 
also a factor that was bothering midwives. Researchers acknowledged the need for 
providing information to the midwives, and in some places regular meetings had been 
organized. The mothers as well as midwives and researchers understood that the general 
knowledge achieved from placenta perfusion studies may be distressing and might make 
mothers feel guilty of their lifestyle. “I cannot think of any risk at all, maybe guilt (Midwife).” 
The proposed benefits for the mothers included the possibility to receive informed 
counselling regarding, for instance, medication and substances that were harmful for the 
foetus. The importance of health promotion was also emphasised as a benefit. The risk to 
midwives was seen by the researchers in the increased workload. “The burden to the mothers 
is limited, but the nurses may think it is a burden when they are busy (Researcher).” In addition, 
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the midwives’ actions when handling the placenta was seen as a risk for the validity of the 
tissue material. “Sometimes you can see that they handle the placenta quite roughly (Researcher).” 
The researchers mentioned that the potential harm may come from working with 
infectious material, e.g. HIV, hepatitis or other infectious diseases. They thought that 
special precautions should be formulated as a written guideline for work with placental 
tissue as potentially infectious biological material. In addition, the future use of samples 
was considered a potential risk or harm to the mother if her identity was not protected. This 
was mostly connected to biobank research. Generally in tissue reseach, the researchers did 
not regard the use of waste sample in research as a potential risk for the participants. Risks 
and benefits were explained quite well in over 80% of the statements. In all statements, the 
difference between research and care was left unexplained and disregarded by saying that 
tissue donation was voluntary. “The issue of bio-banking. Should that tissue be retained or should 
the tissue be burned and disposed of after the study has been done (Researcher).” 
The samples were anonymized for the placental perfusion study, which was considered 
as safe by the midwives and mothers who donated their placenta in the research. There 
were also mothers for whom anonymity was not important in this kind of scientific 
research and who would have liked to have more information about their own placenta.   
The mothers’ trust in the confidentiality was dependent on how well the verbal and written 
information about data processing was given to them. Clear and informative written 
information with the names of the researchers also created trust. 
The researchers pointed out that in their studies, they acted according to the laws and 
regulations about confidentiality, but in practice it always depended on the communication 
between the recruiter and the mother in determining how well the mother understood 
confidentiality. It was considered challenging to inform mothers of the future use of 
samples and their storage e.g. in biobanks in a way that the mothers understood how their 
personal information would be handled. “Identification is not needed if we only study basic 
perfusion and perfusion of different medical products and placentas are from normal uncomplicated 
pregnancies. Identification is needed if the obstetric factors are evaluated with the placental perfusion 
capacity (Researcher).” 
In the ethical statements, researchers explained the handling and confidentiality of 
personal information in over half of the cases. Coding was correctly explained in 51.8% and 
anonymization in 8.9%.  In these cases, coding and anonymization were defined so that it 
was clear for the reader what the author meant by these terms. However, in 3/56 
statements, the meaning of anonymity (no possibility to link data to a person) and coding 
was confused. Half of the cases contained information about who possessed the code key, 
and  32.1% explained how the data will be stored.  
5.3 VIEWS OF THE STAKEHOLDERS ABOUT SOCIETAL MEANING OF 
TISSUE  RESEARCH AND SCIENCE IN GENERAL 
On the basis of the analysis done, when combining data from different papers, the 
societal meaning of tissue research could be clarified by the following themes: scientific 
knowledge, image of science and research ethics.  (Fig 1)  
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Fig.1. Elements of societal meaning given by different stakeholders 
 
Scientific knowledge 
Scientific knowledge which benefits society as a whole was seen as important by all 
stakeholders. According to the researchers, tissue research can be useful for public health 
e.g. in clarifying disease mechanisms and providing possibilities for preventive actions and 
better care. Placental perfusion research was also seen as useful to the society in many ways 
by all stakeholders. They agreed that research would promote the health of children by 
helping to formulate new guidelines for pregnant women and in that way to promote 
children’s health. Especially mothers and midwives clearly expressed the wish to have 
information which was based on science and not on assumptions. Furthermore, most 
mothers and midwives had a positive image about biomedical research in general. "Too 
much knowledge is painful" was a frequent comment among the midwives and mothers 
about scientific research. Although they trusted science, they also perceived threats which 
were worrying or even frightening to them. Their concerns and fears were related to the 
question of where to draw the line in science: what did you have the right to study and 
what not, what could you interfere with, and what could you change in people. Midwives 
were also concerned about the question of financial and academic interests: was the 
research project commercial, did the researchers only wish to add to their own scientific 
merits, or was the participants' point of view also being taken into account. These questions 
revealed critical views about science, and the respondents contemplated issues such as 
research frame, methods and the benefiting parties. They were concerned about research on 
genes and stem cells because they did not possess enough information about such topics. In 
general, however, medical research was highly appreciated by mothers and midwives and 
its benefits to individuals and society as a whole through health promotion were 
emphasised.  
According to the researchers in the placental perfusion study and the principal 
investigators in tissue research, new innovations and usefulness of the research were one of 
the main factors driving scientific endeavour. The mothers clearly expressed that they were 
willing to donate tissues to be used in biomedical research and thought that it was better to 
use human tissues than laboratory animals. Mothers hoped for new innovations in drug 
development. The possibility to prevent diseases rather than treat them was also expressed 
by the mothers. Mothers thought that the usefulness of science in general depended on the 
purpose of the research (Fig.1.) 
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Image of science 
Aspects of societal meaning included the scientists' responsibility for the image of science 
both to the public and to policy makers. Communication e.g. with policy makers and 
research participants was seen as a key to creating a well-informed society.  The midwives 
and mothers thought that politicians and researchers should cooperate, create networks 
and pay attention to informed decision making. They were concerned about money having 
more influence on political decisions than scientific knowledge. It was also emphasized that 
science should be independent and unaffected by political and religious factors.  Midwives, 
mothers and researchers felt that researchers had a responsibility to publish their results in 
such a way that political decision makers and the general public could find and understand 
them. According to their opinions, significant results were based on the skills of the 
researchers and reliable partners such as universities and university hospitals, which were 
also factors in creating trust. Education also created a sense of reliability. They also 
discussed the motives behind the work done by the researchers (whether just for their own 
career or mixed with benefits to society).  One interesting detail was that they also 
wondered how researchers would deal with unexpected results. Midwives were also 
confident when the research organization was trustworthy. Reliability was further 
increased if midwives knew the research group (Fig 1.) 
 
Research ethics  
According to the researchers in placental perfusion studies, ethics is becoming an 
increasingly important part of the scientific process, and researchers have to deal with such 
questions on a daily basis. Some researchers stated that there needed to be a balance: not to 
encroach on the participant's basic rights like privacy but also not to create too much 
protectionism as an obstacle to hinder research. This kind of balance is necessary for the 
benefit of research to society as a whole. Researchers also expressed doubts about whether 
some policies, for instance the handling of applications in research ethics committees, were 
too strict for basic research using human placenta, considering that placenta is generally 
viewed as waste in Western countries. The recruitment process was emphasized by the 
researchers because they find placenta difficult material to work with, and consequently a 
large number of placentas are needed. A good recruitment process is therefore important to 
obtain enough tissue material and improve the quality of the perfusion study. 
Communication was seen as being essential by the researchers to inform society and policy 
makers in order for them to be able to formulate sensible research ethics policies that will 
protect and respect the patients’ interests without making research more difficult than 
necessary.  
Researchers pointed out that they took full responsibility for the ethics in their research 
projects. Midwives noted that commercial research using human placenta could be 
problematic: on the one hand, the products of the pharmaceutical industry would benefit 
everyone, but on the other hand, exclusively commercial purposes were regarded as being 
negative. They believed that even commercial research should benefit society in some way. 
It was a common opinion that placental research that was being conducted as placental 
perfusion did not have any ethical problems if the mothers were informed about the 
research and they gave voluntary, informed consent. It was the general opinion among 
mothers and midwives that mothers were able to decide whether to donate their placenta. 
In Finland, hardly anyone has an emotional or cultural bond to the placenta. International 
researchers have disclosed cultural meanings more clearly and in contrast to the situation 
in Western culture, family or community consent may be required. One important aspect of 
these cultural factors is that the educational level of the donor needs to be addressed. (Fig 
1.) 
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6 Discussion 
This is the first study comparing views of different stakeholders in placental perfusion 
research. Only one study on the views of the mothers and fathers in human placental 
perfusion has been published by Lind and coworkers (2007). Although there are 
publications on the ethical aspects of tissue research, none were found systematically 
analyzing the ethical statements of scientists. In addition only a small number of studies 
concerning the views of nurses/midwives participating in biomedical research was found.  
An important finding in this study was that mothers as well midwives, when rightly 
informed about the purpose of placental perfusion studies, were very interested in the 
studies and supported the use of placenta. The results of this study also indicate that they 
do not perceive any ethical problems or risks related to the scientific use of human placenta 
for anonymous pharmacokinetic studies.  This was in accordance with the opinions of the 
researchers involved in placental perfusion studies. 
The Research Ethics committee of Hospital District of Northern Savo requires that a 
separate statement about ethical aspects is provided by the leading researcher which is also 
in accordance with the recommendation of TUKIJA, The National Committee on Medical 
Research Ethics (TUKIJA 2012).  An interesting and important aspect of the results was the 
insufficient handling of the key ethical aspects in many of the applications submitted to the 
research ethics committee. On the other hand, only the official forms and separate 
statements sheets about ethical aspects were studied and it is possible that the research plan 
in some cases included ethical aspects.  
The discussions about the selected themes with different stakeholders and the analysis of 
the ethical statements revealed several ethical aspects of particular interest in tissue 
research. On the basis of this, following aspects will be discussed here: aspects of the 
informed consent process, collaboration with different stakeholders and education, 
confidentiality, risks and benefits as well as societal aspects. One important outcome of this 
study was the identification of several critical points about the informed consent process of 
tissue research in a clinical setting. The most obvious gaps identified in the process were 
the conceived insufficient interaction between the researchers and nurses/midwives as well 
as between the recruiters (midwives or researchers) and the research participants. In some 
cases, the time for the decision process available for the participants was regarded as too 
short. On the whole, researchers should consider more carefully the recruitment and 
informed consent processes and the ethical aspects of their research. (See Fig. 2).  
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      Existing gaps in the process 
Fig 2. Aspects of the informed consent process as emerged from this study  
6.1 ETHICAL ASPECTS OF INFORMED CONSENT AND RECRUITMENT 
PROCESS 
In the literature the complexity of informed consent process has been described in various 
contexts (e.g. Mason et al. 2000, Hunter 2006, Kass et al. 2007, Länsimies-Antikainen et al. 
2007, 2010a,b, Halila 2007, Parvizi et al. 2008, Wendler & Grady 2008). An aspect of our 
study, not much discussed in the literature, is the comparison of the views of the different 
stakeholders in particular projects.  This has allowed a more holistic view of the informed 
consent process (see also Beauchamp & Childress 2001, Vähäkangas 2004). Also this is one 
of the first studies on the views of different stakeholders in tissue research. (Fig.2).  
In accordance with the literature we found that understanding of research information is 
limited among research participants (Crepeau et al. 2011, Desch et a. 2011, Monson et al. 
2012). There is a consensus in the literature that research participants may totally 
misunderstand clinical trials in which they agree to participate (Jefford & Moore 2008, 
Schwartz & Appelbaum 2008, Wendler 2011) and they may have difficulties in 
remembering the actual signing situation (Hamilton et al. 2007, Falagas 2009). In our study 
based on the thorough interviews, it became clear that the comprehension of the study itself 
was difficult to keep in mind (I,II). The mothers in general could not remember the purpose 
of the study, until they were reminded during the interview, although all but one of the 
mothers remembered that they had signed the consent form.  Therefore, it was surprising 
that the analyzed statements on ethical of the scientists (IV) included very little information 
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and considerations about the recruiting in clinical settings and the associated ethical 
aspects. In earlier studies (Länsimies-Antikainen et al. 2010a,2010b, Lynöe et al. 2004, 
Hamilton 2007, Behrendt et al. 2011) it has been shown that it is important to consider the 
actual situation when the signature is gathered from the participants. In general, timing has 
been considered as being an important aspect (Vähäkangas 2008, Hamilton et al. 2007). This 
theorical understanding is contributed by a limited number of studies on how much 
information the research participants comprehend (see e.g. Crepeau et al. 2011, Desch et al. 
2011, Monson et al. 2012).  Manson & O`Neil (2007) have emphasized that signing the 
consent should fulfill legal as well as ethical requirements. Therefore the consent process 
should not be only formalized routine and regarded as protection against liability, but 
resulting with a true honest aim to understand the informed consent and the study.  
All stakeholders in human placental perfusion studies considered the delivery as a very 
sensitive situation with emotions ranging form joy to fear (I-III). It is well-known that 
strong emotions may impair understanding of the given information (Helmreich et al. 2007, 
Vernon et al. 2006) as also shown in this study.  It is also well-known that obtaining an 
informed consent in an ethically justifiable way from women close to labour (Dorantes et al. 
2000, Vernon et al. 2006) or even generally in clinical settings (e.g. Cahana & Hurst 2008, 
Hewitt et al. 2009) is challenging. In accordance with the literature found that 
understanding of research information is limited among research participants (Crepeau et 
al. 2011, Desch et al. 2011, Monson et al. 2012).   
This study showed also that some midwives considered participation in the recruitment 
process problematic in practice, especially if the clinical work was hectic. Nevertheless, the 
delivery room was seen as an adequate recruitment location for placental perfusion studies 
by both mothers and midwives. Both the midwives and mothers told that the participating 
mothers tend not to ask questions about placental research, which may be explained by the 
fact that placenta is generally considered as waste after delivery. Nonetheless, both groups 
(I, II) regarded dialogue as beneficial in providing relevant information to the mothers. 
Personal interests in science of the midwives also affected the manner in which they 
provided information (II) which is accordance with earlier study (Potter et al. 2009). Those 
who expressed interest in science were willing to learn more about recruitment as well as 
research in general. All in all despite the challenging circumstances in the delivery room or 
in the ward and the concerns expressed by the midwives, it was a general feeling by all 
stakeholders that the mothers' decision to participate in the perfusion study was a 
voluntary choice although in some cases time for decision was regarded as too short.   
Recruiting during delivery was discussed during the interviews. Indeed, there were 
general consensus that recruitment should take place during early labour and this also has 
been pointed out in the literature on the view of mothers (see e.g. Vawter et al. 2002, Lind et 
al. 2007). Vawter and coworkers (2002) stressed that the recruitment for research must take 
on account the ability of the mothers to receive information and therefore, to ensure 
understanding it would be important to repeat the information about the study after 
delivery.  These findings call for amendments to be made in the practices in placental 
perfusion studies and stressed the importance to carry out this kind of project. In individual 
research much more could be done than currently is the case to study the practical ethics 
concurrently with the actual studies. It is also evident that more research is needed on the 
points of view of participants, and especially midwives or nurses in placental studies.  
However, most researchers in placental perfusion studies were content about the 
recruitment process in their organizations (III). It is noteworthy that in the ethical statement 
the scientists did not point out the putative ethical aspects of the actual signing situation, 
and only a few of the studied statements discussed how the competence and understanding 
of the participants would be ensured. Moreover, in these statements voluntariness was 
usually mentioned only very briefly in one sentence (IV). In this study the researchers (III) 
also noted this as a possible problem and pointed out that in Western thinking, the placenta 
is mostly considered as waste. Some researchers suggested that current guidelines and 
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processes for obtaining informed consent should be reviewed also from a cultural 
perspective. Research into the validity and user friendliness of information sharing 
procedures to obtain the consent in different cultural settings would be very beneficial 
(Bhutta 2004, Jenkins & Sugarman 2005). This indicates that opinions of all stakeholders are 
very crucial when improving the recruitment situation in order to take on account the 
multidimensional aspects of the consent process.  
In this study, mothers were interested to know about the research in which their 
placentas would be used since benefit to others was the reason why they had decided to 
donate the placenta. Also Lind and coworkers (2007) showed that mothers who donate 
their placentas to the perfusion studies were interested in the purpose of the research, and 
the reason for donation was beneficence for society. This has been pointed out also in other 
type of tissue research, by many authors (see e.g. Hansson et al. 2006, Hemminki et al. 2009, 
Hens & Dierick 2010, Morrell et al. 2011).  
In conclusion there has been intense discussion about the form of informed consent in 
scientific research in the literature during the past few years (Van Diest 2002, Savulescu 
2002, Aromaa et al. 2003, Knoppers 2004, Vähäkangas 2004, Hansson et al. 2006, Hunter 
2006, Wendler 2006, Hansson et al. 2007, Hamilton et al. 2007, Cahana & Hurst 2008, 
Schwartz & Appelbaum 2008, Hewitt et al. 2009, Hofmann 2009, Secko et al. 2009, Toccaceli 
et al. 2009, Budin-Ljøsne et al. 2011, Wendler 2011, Stjernschantz Forsberg et al. 2009, 2010, 
2011). In particular, there is growing support for a broad consent (also described as open, 
generic or blanket consent) in tissue research, particularly in biobank research (Kaye 2004, 
Hansson et al. 2006, 2007, Stjernschantz Forsberg et al. 2009, 2010, 2011). One justifying 
reason for this situation has been the belief that research participants generally do not want 
to know the exact purpose of the research where their tissues will be used (Stjernschantz 
Forsberg et al. 2009, 2010, 2011, Treweek et al. 2009). On the other hand, in the future, it is 
predicted that there will be increased awareness of the rights of participants to maintain 
control over their samples or personal information (Kaye 2004, Hofman 2009). It is 
noteworthy that the discussion about the form of different consent applies only to 
propositions for the form of consent but not acts of consenting and decision making 
process. According to Manson & O´Neil (2007) more important is good communication 
between different stakeholders. Therefore an ethical discussion about the way that 
informed consent has been obtained, especially in terms of ethical rights, needs to continue 
(see e.g. Takala 2004, Vähäkangas 2004, 2008, Manson & O´Neil 2007, Tupasela et al. 2010). 
6.2 COLLABORATION WITH HOSPITAL PERSONNEL AND EDUCATION 
ABOUT ETHICAL ASPECTS 
The results of this study show that researchers, as well as other stakeholders in placental 
perfusion studies, considered communication between all stakeholders as being extremely 
important (I-III). Good communication was linked not only to successful recruitment and 
informed consent process, but also to voluntariness to participate, confidentiality and 
societal meaning. Communication is an aspect which has also been known to clearly affect 
the success of human recruitment in general (Hietanen et al. 2007, Länsimies-Antikainen et 
al. 2010b). Researchers (III) pointed out also a practical reason for enhancing good 
communication: to obtain enough placentas and in this way to promote the quality of the 
research.  
A major ethical issue is how to educate the recruiters when they are not part of the 
research group i.e. how to best inform nurses/doctors about the research in such a way that 
they can provide relevant information to the participants. The studied researchers (III) 
considered training of the hospital personnel as being essential in order to provide the best 
possible information to the mothers donating their placentas. They thought that this 
guidance would also improve the informed consent process, in agreement with the existing 
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literature (Brown et al. 2007, Hietanen et al. 2007). Nevertheless this aspect was missing in 
the ethical statements of most of the scientists, when the recruiter came from outside the 
research group. Furthermore, previous studies (Lavori et al. 2007, Jerosch-Herold et al. 
2011) have observed that even if planning is done carefully and information is given to the 
recruiters in practical terms, the recruitment in practice can be very challenging as shown 
also in this study.    
In placental studies, it is rather common to use midwives as the recruiters (Audette et al. 
2010). According to this study, the midwives in university hospitals considered research to 
be an important part of their work and in principle they were happy to serve as recruiters 
and work with different research teams.  There is a conflict in this situation i.e. on one hand 
mothers prefer that midwives act as recruiters but on the other hand midwives cannot have 
access to all the details about the study that mothers might wish to know. According to 
previous studies nurses feel that they do not have enough understanding of various 
methodologies and the general issues inherent in scientific research, and thus more 
education is required (Kuuppelomäki & Tuomi 2003, Peter et al. 2004, Kuuppelomäki & 
Tuomi, 2005, Roxburgh 2006, Merry et al. 2010). In spite of the information being given to 
the midwives, only one of the 20 midwives felt that she had good knowledge about 
placental perfusion research and 12 stated that they had an unclear idea about the purpose 
of the research. The fact that the wards are large with many nurses and with continued 
changes to staff makes it difficult in practice to keep everybody in personal contact with the 
researchers. It would be important in the future to find the best ways and situations to 
educate the nurses about all of the research on-going in the maternity wards. One such 
forum could be a webpage where the information would be given in detail.  However, this 
would then require the management to convince the nurses to take the time to visit the 
page (Merry et al. 2010). In the training of staff in university hospitals these kinds of 
instructional possibilities should be utilized more but this is naturally dependent on the 
availability of resources. It has been discussed in various research contexts i.e. who is the 
best recruiter of participants for scientific projects in biomedicine and health (e.g. Donovan 
et al. 2003, Mapstone et al. 2007). It is evident that researchers know the project thoroughly, 
but, the intense need to gather participants may lead to coercion (see e.g. Sugarman et al. 
1999). Interestingly, Donovan and coworkers (2003) have suggested that recruitment for 
clinical trials could be carried out by nurses as effectively as doctors as and more cost-
effectively than recruitment by doctors.   
In general, and in accordance with earlier studies (Sale 2007, Merry et al. 2010) the nurses 
interviewed here felt that their work as the recruiters of participants to scientific research 
had gone unacknowledged. The midwives felt that sufficient information would also 
motivate them to recruit more efficiently and better. Researchers (III) expressed some 
concerns about the ability of the midwives to provide accurate information about the 
complex research model and the aims of the studies. This opinion was also supported by 
the information provided by the mothers (I). The researchers (III) suggested that midwives 
should be part of the research team acting as research nurses to ensure the flow of 
information and good communication. However, extra resources would be needed for 
research nurses or midwifes. Moreover, organizations should also provide leadership in 
support of responsible practical conduct of research (see e.g. US National Research Council 
2002).  
In summary, ensuring good communication with different stakeholders would improve 
the quality of research by avoiding at least some technical and ethical failures. This matter 
should be taken into consideration in study plans and be transmitted to funding agencies. It 
may well become a requirement that there is funding to support additional staff like 
research nurses or midwives is included not only in grant requests for clinical studies but 
also for experimental studies with human tissue such as the placenta.  
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6.3 ETHICAL ASPECTS OF CONFIDENTIALITY, RISKS AND BENEFITS  
Confidentiality of the research is a basic legal and ethical requirement that has been 
emphasized in many international guidelines, e.g. the Declaration of Helsinki and in 
national legislation, e.g. the Finnish Medical Research Act, Act of Medical Use of Human 
Organs and Tissues and Personal Data Act. In the literature, confidentiality has been raised 
as an important factor in the field of tissue research, because of the possibility of accessing 
genetic information (Hull et al. 2008, Tännsjö 2011, Ursin 2010). In this study the meaning of 
confidentiality in placental perfusion studies to mothers and midwives was less significant.  
According to the thematic interviews of the mothers and midwives, it seemed that 
confidentiality of personal information was not important to the mothers (I,II). Mothers also 
regarded their privacy being respected which is in accordance with the earlier study by 
Leino-Kilpi and coworkers (2002). One reason for the opinions of the mothers may be that 
the perfusion studies carried out with their placentas were not genetic research. They 
probably did not know that placenta and cord blood could be used also in genetic studies. 
In many perfusion studies, including the studies with their placenta, the placenta is 
anonymised prior to its use in the study. After anonymisation, it is impossible to provide 
personal specific information of the function of their own placenta to the mothers although 
they have wished for this information. Mothers studied here did not regard anonymity of 
the placentas being as important; a more important for to them was the potential benefit to 
the children and society (I).  
Approximately 64% of scientists considered confidentiality in their statements to the 
ethics committee (IV). The others may have explained confidentiality in the research 
protocol or some may not have considered confidentiality as an ethical issue. Furthermore 
in the literature the terminology might be confusing, for instance the definitions of 
anonymity and coding are poorly defined (Vähäkangas 2004) which also was the case in 
some analyzed statements. It is clearly challenging to make the studies understandable to 
lay people and some details may even be confusing both to scientists and the participants.  
Thus the scientific community should pay attention to clarification of scientific 
terminology, which actually may be regarded also as an ethical requirement in human 
studies. 
The so-called therapeutic misconception, which means that the participant thinks that 
the study is part of the treatment, is regarded to be a common situation in clinical studies 
(Lidz et al. 2004, Appelbaum & Lidz 2006). This kind of misunderstanding can easily occur 
when the recruiter is the patient's own doctor or recruitment is performed during clinical 
care. The ethical issue here is how to explain the difference between medical care and 
research to the patient. This consideration was missing from the ethical statements of the 
scientists (IV), even though 80% of the studies were dealing with tissues being removed as 
part of clinical care. Probably, many scientists simply regarded the leftover tissue sample as 
a waste, and no concern for the patients, and therefore they had not discussed the matter in 
ethical statements. It is noteworthy that a failure to recognize the difference between 
scientific research and ordinary medical care negates the ability of a potential participant to 
provide a meaningful informed consent (e.g. Hofmann 2009). Moreover, it has been lately 
discussed whether the distinction between research and medical practice is already too 
strict (see e.g. Beauchamp 2011, Hansson & Chadwick 2011, Largent et al. 2011). 
Additionally, it has been discussed  whether the type of tissue research e.g. the invasiveness 
of the procedure, autopsy specimens, healthy volunteers (see e.g. Vähäkangas 2004, Kapp 
2006, Gillet 2007, Tassé 2011) should influence the ethical evaluation process. Also in this 
study, some researchers in the interviews and questionnaire called for a balance between 
protecting the participants' basic rights like privacy while keeping research procedures free 
of unnecessary obstacles. 
In this study, the researchers stressed that the research on placenta involved no physical 
risk to the mother and the baby and thus there were minimal ethical dilemmas from that 
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point of view. Some burden to nurses was perceived, such as the extra work (see e.g. Sale 
2007). The researchers thought that mothers might perceive as a risk some type of guilt 
related to their own lifestyle, e.g. smoking, a finding found in the opinions of both the 
mothers and midwives. The future use of the placentas was regarded as a potential 
problem if confidentiality was not protected by the researchers.  
Even though the mothers did not consider confidentiality as important, it is evident that 
confidentiality will become one of the important factors in biobank research like stated in 
Government Bill of Biobank Law (see e.g. HE 26/2011). It will be challenging to explain the 
concept of confidentiality of the data for research participants, especially whether they are 
giving consent for a certain study or providing a broad consent. However, this is an 
important point if one wishes to obtain a truly informed consent from the participants. (See 
fig. 2).   
6.4 SOCIETAL MEANING OF SCIENCE 
The importance of societal meaning of the scientific research was considered as significant; 
especially the scientists stressed this point in their ethical statements (IV). Also stakeholders 
in placental perfusion studies regarded science as significant for promoting health and 
developing new innovations (I-III). In this study both mothers and midwives expressed 
their trust in science. It is well- known that Finnish people consider science to be a 
trustworthy activity, especially medical science and the work done in universities 
(Hemminki et al. 2009, Finnish Science Barometer 2010). Finns also trust in the regulatory 
authorities such as research ethics committees (Special Europarometer 2010). The midwives 
were asked about the meaning of science in general, and they considered scientific 
information as being important. This has been noted also in other countries (Meah et al. 
1996, Peter et al. 2004). The midwives mentioned stem cell and genetic research as examples 
of areas of concern, because they considered these areas as unfamiliar. They were unaware 
of the fact that placenta and cord blood are important sources for stem cells (Locatelli and 
Burgio 2002) and they expressed no concern about the use of placenta in scientific research 
in general. On basis of this, in the future attention should be paid especially on the 
education of midwives and on the information provided to the recruiters by the research 
groups. Furthermore, it should not be taken for granted that lay people are willing to 
support scientific biomedical research. Participation in research e.g. by donating tissue 
samples, is based on trust and this has to be gained and retained if scientific research for 
biomedicine to thrive in our society (Merlo et al. 2007). There is a consensus in the literature 
that the future of the research is dependent on trust (Merlo et al. 2007, Savulescu 2002) and 
education of the general public is the key to enhancing trust in research involving human 
tissues (Savulescu 2002).  
Based on the analyzed data the societal meaning of tissue research was perceived as a 
multidimensional topic, ranging from the creation of new knowledge to enhancing the 
capability of the scientists to communicate with the public (I-IV). Scientists involved in 
placental perfusion studies were of the opinion that research on placenta will increase in 
the future (III). All stakeholders in the placental studies regarded active communication  as 
imperative for informing the public in addition to the scientific community of the results 
obtained, which in turn is beneficial for the development of the method (I-III, see also 
Lercher 2010). Researchers also pointed out that ethics is becoming an increasingly 
important part of the scientific process, and researchers have to deal with such questions on 
daily basis. It was notable that in the interviews of researchers, Campbell and coworkers 
(2008) found that ethical aspects were not considered in the day-to-day decision making by 
professionals in the research. Therefore they pointed out that greater attention will need to 
be paid on ethical training and debate.  
47 
 
 
The guidelines of the Ethics Committee of the Hospital District of Northern Savo state 
that researchers must consider the justification for the research in their ethical statements. 
Furthermore, the Declaration of Helsinki, as well as other guidelines and regulations, 
require that research should be based on earlier literature and this should appear in the 
research plan (WMA 2011). One of the most important justifications for doing biomedical 
research is its benefits to patients in the form of improved patient care i.e. acquiring 
knowledge for diagnostic, therapeutic and prognostic purposes. Nonetheless, the studied 
statements (IV) contained little information about the societal meaning of the proposed 
research. Similarly to confidentiality, societal justification is a topic that may not be 
perceived as an ethical aspect, and this may have been described in the research plan. It 
was common for the researchers to simply repeat the research protocol in their statement, 
which in many cases did not include the justification. It was noticeable that the ethical 
statements were more structured in 2006-2009 than in 2004-2005. By 2006 the ethics 
committee had already formulated the requirements for the details that needed to be 
included in the ethical statement. Thus, in this study although the formal requirement and 
advice from the ethics committee had a positive effect on the written statements, it is still 
unclear how ethics instructions should be given (see e.g. Anderson et al. 2007, McCormic et 
al. 2009, Antes et al. 2010). This is in accordance with the call for more training among 
scientits to acquire the capacity and knowledge for deeper understanding of the ethical 
aspects of research (Faber et al. 1992, Mertz et al. 1999, Paul 2000, Taylor et al. 2008). In 
earlier studies (Mertz et al. 1999, Keinonen et al. 2001, Bueno et al. 2009) it has been shown 
that most of the clarifications requested from the researchers by the committees dealt with 
the informed consent process. Therefore, knowledge and education about research ethics is 
needed and experience about research should be initiated as early as possible, for example 
in courses to undergraduates like Faber and co-workers suggested already in 1992. It would 
be helpful to both the scientists, and nurses, if ethical concepts like voluntariness and 
informed consent were to be clearly explained in practical manner in educational courses 
(see e.g. Appelbaum et al. 2009).  
The fact that ultimately it is the scientists who are responsible for the good ethics of their 
research was also noticed in this study by the scientist. Otherwise there is a general 
consensus in the scientific community that scientists themselves should consider ethical 
aspects as an integral part of the research process (Grandjean & Sorsa 1996, Vähäkangas 
2004, Wendler 2011). The demands that certain types of research require less information to 
the participants or a different kind of consent as well as lighter ethical review process may 
be problematic. It has been stated that self-regulation of the scientists is not enough (see 
Holm 2011) and questions have been raised about the best way to perform this assessment. 
It will be challenging to develop an informed consent process that is valid for future studies 
in which the samples may be reused (see table 2 requirements of legislations in Finland i.e. 
Act of Medical Use of Human Organs and Tissues). Especially how confidentiality is 
ensured in megastudies is unclear. For instance, one practical difficulty is that it would be 
extremely difficult and time-consuming to re-contact all subjects in order to gain a new 
consent for a reuse in research especially if thousands of people were involved (Petrini 2010 
a,2010b, Hansson et al. 2006). These issues can only be clarified by further studies and in 
discussions about ethical review process and documents.  
The interviewed midwives regarded the use of human placentas for commercial 
purposes as problematic, with the exception of their use for pharmaceutical research. 
However, the midwives felt that the recruitment for commercial research would be more 
challenging, because they felt that in such a case, the purpose of the research would need to 
be clarified to the mother in detail. Earlier studies have reported similar results (Hens & 
Dierickx 2010, Morrell et al. 2011). Nevertheless, Hemminki and coworkers (2009) have 
reported that there was no difference in Finnish attitudes about whether research was being 
conducted by a public or private enterprise. Balancing of ethical benefits and costs (Zwitter 
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& Colouh 1996) in the commercial use of human tissues in general has been stated to 
demand much more studies than currently exist (Hemminki et al. 2009).  
Although the procedures in some cases did not materialise exactly as planned in 
perfusion studies, the mothers were still content because they considered the placenta as a 
waste product and they were satisfied that it could be put to some beneficial use. In 
Western countries placental tissue is considered as waste after the birth. The interviewed 
mothers considered that it was their own decision to donate their placenta. However, this 
may not necessarily be the case in other countries (Jenkins & Sugarman 2005). Researchers 
in placental perfusion studies stressed that this topic has implications involving also 
cultural dimensions. In general, the cultural aspects in tissue research have attracted little 
attention in placental research (Jenkins & Sugarman 2005) or in biomedical research in 
general (Bhutta 2004, Glickman et al. 2011). Also, it has been stressed that there will be a 
shift of perspective in biomedical ethics into a more global (Ijsselmuiden et al. 2005, 2008, 
2010, Prainsack & Buyx 2011) and towards solidarity (Lev 2011, Prainsack & Buyx 2011) 
also research with human tissue (Prainsack & Buyx 2011). Latest report of Nuffield Council 
on Bioethics stress importance of solidarity especially in biobank research (Prainsack & 
Buyx 2011). Also, WHO (2011) have stressed the importance of selection of study 
population and community-based considerations in the ethical review process. They have 
also encouraged researchers actively engage with communities in decision-making in 
research and being sensitive to respect cultural, traditional and religious practices.  
However, one must not conclude that cultural considerations must always dictate that 
members of certain groups’ communal autonomy will always take precedence over 
individual autonomy (UNESCO 2008). 
In summary, the societal aspects of science are extremely important and more attention 
should be paid to this topic in education and science as well as in society at large. Lately, 
the ethical importance and influences of sources of funding, institutional affiliations and 
conflicts of interest have been highlighted (WMA 2011). These aspects were missing from 
this present study. Clearly these topics must be addressed in future studies. The image of 
science is also dependent on the capability of the scientists to convey the results of their 
work in comprehensible language to the general public. This will enhance the trust of lay 
people as well as political decision-makers. The scientific community should not take this 
trust for granted, and thus the scientist should listen closely the opinions of different 
stakeholders. 
6.5 RELIABILITY OF THE RESEARCH  
According to Tong and coworkers (2007) the reliability of a study can be assessed by 
examining the study design, and by evaluating the analytical process and the findings. The 
themes considered in the interviews of both the mothers and the midwives were the same 
to ensure comparability of the results (I,II). The interview themes in the focus groups (III) 
were also created out of the themes raised in the two previous studies (I,II). The focus 
group interviews were complemented with a questionnaire whose open-ended questions 
were derived from the interview themes discussed former studies 1-2. The ethical 
statements (IV) were analyzed by using an ethical framework which was derived from the 
interview themes. Due to the data and method triangulation in all four studies, the results 
can be regarded as an entity, and this enhances the validity and credibility of the study. 
Triangulation helps to obtain a more complete and contextualized portrait of the 
phenomenon being studied. Data source triangulation was ensured by using multiple 
sources of data, i.e. from the mothers, nurses, researchers and documents (see e.g. Polit & 
Beck 2006) and method triangulation by using different methods (see e.g. Lambert & 
Carmen 2007) in this study e.g. focus-group and questionnaire for the researchers (III).    
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As a way of guaranteeing the credibility, participants in the first three studies (I-III) were 
selected so that they had been involved in some way in placental perfusion studies. All 
interviews were conducted by the same member of the research group which was 
considered as a way of improving the reliability in the comparison of the data. Interviews 
with the midwives were carried out mainly during their working hours, which may have 
influenced the total time spent in the interview. The place was carefully selected to ensure 
privacy. Saturation, which means that new aspect did not emerged (Polit & Beck 2006), 
became apparent after 16 interviews with the mothers (I), 18 interviews with the midwives 
(II) and after 3 focus- group interviews with the researchers (III). After the interviews had 
been transcribed, the written texts were compared with the original interview material to 
ensure that the transcription had been accurate. Although the material was analysed by one 
researcher, the multidisciplinary research group discussed the results at different stages of 
the analysis, which can be called investigator triangulation. The research group also 
worked together in reviewing the conceptualisation process and the concepts to be selected 
(for more discussion on triangulation see e.g. Polit & Beck 2006, Tong et al. 2007). Although 
the findings do not represent the views of all stakeholders in tissue research, the saturation 
of opinions with this the number of interviewees gives confidence that the results are 
reliable. This implicates that the results of this study can be utilised not only in Finnish 
placental perfusion studies, but also in general in studies requiring recruitment and 
informed consent procedures.  
The focus group interview is a method where participants are encouraged to 
communicate with each other, ask questions and comment on each others' experiences and 
points of view (Kitzinger 1994, 1995, Barbour 2010). This method was chosen as a way to 
obtain a consensus about ethical aspects in perfusion studies and also to provide the 
scientists involved with a possibility to gain new perspectives. The purpose was not to 
gather individual comments, these were handled in the data analysis. On the contrary, the 
aim was to formulate a collective understanding about the topic.  The language used in the 
focus-group interviews was English but this was not, of course, the native language of all 
participants. However, the participants were scientists and used to using English as a 
scientific language (see e.g. Barbour 2010). In the study III, two methods were used,  focus-
group interview and a questionnaire, both of which were very useful for the objective of 
obtaining a deeper understanding of the views of the researchers  about ethical aspects. 
This made it possible produce information in a comprehensive manner, which was 
considered to strengthen this study. Furthermore, the results gained by both methods 
complemented each other. The analyses were done with the NVivo programme which  
proved suitable for this kind of study. When comparing NVivo analysis with the manual 
analysis used in study 1, it seems that the NVivo technique is not only more systematic but 
also more focused  (see Bergin 2011). 
Research involving documents is increasing (Al-Qadire et al. 2010, Prior 2010), and 
thematic analysis is an appropriate method for working with this kind of material (Prior 
2010). In order to analyze the validity of documents, the analysis must consider the contents 
of the documents. In the statements of the ethics studied here (IV) the contents varied from 
a few sentences to long deliberations. Thematic content analysis was considered as the best 
method because of the variation in the length of the documents as recommended by Prior 
(2010).  Thematic content analysis also makes it possible to use quantitative methods 
(Sandelowski 2001, Sandelowski et al. 2007). The topics of the statements about the ethics of 
research also were formulated according the instructions by the ethics committee. Such 
detailed instructions are commonly used and can lead to a certain type of text in the 
statements as also pointed out by Prior (2010), and this must be remembered, when 
drawing conclusions. A typical example is the concept of voluntariness which was used as 
a word without further explanation. On the other hand, when scientists had an opportunity 
to write a “Free statement,” the content was less comprehensive than those that were 
written according to the instructions. In this case structured format may have lead the 
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scientists to just answering the requiring points and not challenge scientist to deeper 
consideration about ethical aspects in their research. 
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7 Summary and conclusions 
1. The results of this study indicate that stakeholders, i.e. donors, recruiters and researchers, 
do not perceive any ethical problems or risks related to the scientific use of anonymized 
human placenta for pharmacokinetic studies involving placental perfusion. All 
stakeholders considered scientific research using human tissue as important, especially if 
the research benefits the society as a whole. It was notable that all stakeholders in perfusion 
studies have similar views about most of the themes used in this study.  
 
2. The success of the research on human tissue requires fluent collaboration between 
different stakeholders. Both the studied nurses and mothers expressed that the decision 
process towards informed consent should be a dialogue between the stakeholders to ensure 
true informed consent from the participants. Based on results of this study and earlier 
literature it is clear that the informed consent process is challenging in the clinical setting. 
Thus, it is imperative to determine the factors influencing in the recruitment and informed 
consent process. Results also indicate that this is not possible without taking on account of 
the management and research governance. Therefore more research is needed concerning 
tissue research and the process of informed consent as well as on the stakeholders involved 
that process, also from the point of view of management and research governance.  
 
3. Based on the opinions of the researchers in placental perfusion studies, the recruiting 
nurses or other persons should be part of the research team to ensure that the participants 
receive accurate information. Nurses pointed out that, more education about the methods 
and aims of the projects should be provided to them when they are involved as recruiters. 
This was also supported by the researchers. Nurses have an important role in recruiting 
patients for scientific research and therefore more research is needed to clarify further their 
opinions. 
 
4. According to the stakeholders of tissue research societal meaning of tissue research is 
multidimensional and includes e.g. the significance of scientific knowledge, image of 
science and aspects of research ethics. Active communication was regarded as essential and 
according to all stakeholders should include both the general public and the scientific 
community. The scientist pointed out that Finland is already a multicultural country and 
global collaboration is increasing. Therefore, future studies should focus also on the 
cultural aspects of biomedical ethics. 
 
5. The results of this study showed that ethical statements of the scientists were quite 
shallow. The significance of ethical questions in the use of human tissue for research 
purposes will probably increase in the future, especially when more biobanks of human 
tissues are established. In order to obtain more generalized information, it is essential to 
review other ethical statements and study protocols. In addition, it would be important to 
gather the views of participants about tissue research in general, for example about the 
commercial use of human tissues. Additionally, continuing education about research ethics 
is needed. 
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Views of the Stakeholders
Ethics is a central aspect in scientific 
research and it is more than law. 
The aim of this study was to describe 
the ethical aspects of human tissue 
research and to learn how the stake-
holders in research involving human 
tissues perceive their participation 
and how the protection of their rights 
is guaranteed by current ethical 
practise. Research using human tis-
sue may increase in the future e.g. 
when large biobanks are established. 
Views of different stakeholders in 
research could contribute to research 
ethics by both improving the ethical 
conduct of recruitment and increas-
ing participation.
